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ABSTRACT
Dynein is an essential motor protein required for the maintenance and survival of
cells. Dynein forms a motor complex to carry intracellular cargoes like organelles,
growth factors, peptides, and hormones along the microtubules inside the cells.
In neurons, the dynein is the retrograde motor protein that moves cargoes from
the neuronal tip to the neuronal soma along the length of an axon. Dynein has an
established role in neuronal nuclear migration, transport of neuronal survival
signals and growth factors, organelle positioning inside neurons etc. Hence, it is
not very surprising that numerous mutations in dynein have been reported in
association with neurodegenerative diseases in humans. The first human
mutation (H306R) in dynein heavy chain was reported to cause Charcot-MarieTooth Type 2O disease (CMT2O) in humans. CMT2O patients display motorsensory neuropathy symptoms such as muscle weaknesses and wasting in legs,
skeletal deformities like pes cavus (high foot arching), difficulty in walking, and a
loss of sensation.
We developed a novel knock-in H304R mouse model with the corresponding
CMT2O linked dynein mutation to understand the disease’s molecular
mechanism. We investigated and characterized the motor-sensory phenotype of
the H304R mouse model (wildtype, heterozygous (H304R/+) and homozygous
(H304R/R) mice). First, we started with testing mice on motor skills behavior
tests such as tail suspension reflex, grip strength test, and rotarod test at 3, 6, 9

iii

and 12 months of age. Both male and female groups of heterozygous (H304R/+)
mice displayed mild defects in tail suspension reflex, grip strength, and rotarod
performance. In contrast, homozygous (H304R/R) mice exhibited severe defects
in the tail suspension reflex, grip strength, and rotarod performance right from an
early age. Next, I analyzed the sensory phenotype of the H304R mouse model.
Homozygous H304R/R mice appeared to have thinner sciatic nerves, reduced
total fascicular area of the sciatic nerve, and significantly quicker latency to tail
withdrawal from a pain stimulus than the wildtype and heterozygous H304R/+
mice.
Collectively, our motor and sensory characterization studies reveal that H304R
dynein mouse model recapitulates many of the phenotypes associated with CMT
symptoms. Hence, the H304R model is a useful tool in understanding the dynein
function in the onset and progression of CMT2O in humans.
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CHAPTER 1: INTRODUCTION
Dynein is a motor protein present ubiquitously in many living organisms ranging
from small microorganisms (yeast, fungi, parasite etc.) to humans. One of the
many functions of dynein is to carry intracellular cargo on microtubule tracks
(Paschal and Vallee, 1987). Microtubules are polarized cytoskeletal filaments
that are usually arranged with their growing plus ends at the cell periphery and
their minus ends at the microtubule-organizing center (MTOC) at the cell center.
Dynein utilizes adenosine triphosphate (ATP) as an energy source to power its
motor function and carries cellular cargoes from the cell periphery to the minus
end of the microtubule at the cell center (retrograde). In contrast, the motor
protein kinesin carries the cellular cargoes from the cell center to the plus end of
the microtubule that is usually located at the cell periphery (anterograde).
In eukaryotic cells, there are 3 classes of dynein – cytoplasmic dynein 1,
cytoplasmic dynein 2, and axonemal dynein (Wickstead and Gull, 2007) (Yagi,
2009). Cytoplasmic dynein 1 is involved in minus end directed transport within
the cell body and has extensive cellular functions ranging from intracellular
transport to cell division activities (listed in the Table 1-1). Cytoplasmic dynein 2
acts as a motor protein inside cilia/flagella and is involved in intraflagellar
transport of structural components for flagellar assembly (Pazour et al., 1999).
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Figure 1-1 Intracellular motility inside a cell
Motor proteins dynein and kinesin carry cargoes like mitochondria and vesicles on the
microtubule tracks. Dynein is minus end directed motor protein, while kinesin is plus end
directed motor protein

Cytoplasmic dynein 2 transports cargoes from the tip to the base of cilia where
the minus end of microtubule is located (Porter et al., 1999). The axonemal
dynein is integrated with the microtubule to make the core structure of cilia called
axoneme (Gibbons and Rowe, 1965). Axonemal dynein is involved in powering
the ciliary beating to make the cilia and flagella motile. Cytoplasmic dynein 1 will
be referred just as ‘cytoplasmic dynein’ or ‘dynein’ from now on in this document.
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1.1

Cytoplasmic Dynein Structure

Dynein is a large multimeric protein complex that is ~1.2 megaDalton in size. A
functional dynein motor unit (Figure 1.1) is comprised of many subunits – 1 pair
of dynein heavy chains (DHC), 1 pair of dynein intermediate chains (DIC), 2 pairs
of dynein light intermediate chains (DLIC), and 3 pairs of dynein light chains
(DLC). The dynein heavy chain (DHC) monomers dimerize at the N-terminal to
form a heavy chain dimer that interacts with other dynein subunits (DIC, DLIC,
DLC) to form a functional dynein motor complex.

Dynein heavy
chain (DHC)

DLIC
DIC
DLC
Figure 1-2 Cytoplasmic Dynein Structure
Dynein is a multimeric protein comprising of subunits - dynein heavy chain (DHC),
dynein light intermediate chain (DLIC), dynein intermediate chain (DIC) and dynein light
chain (DLC). Dynein heavy chain has six ATPase heads and a microtubule (MT) binding
domain.
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1.1.1 Cytoplasmic Dynein Heavy Chain Structure
The cytoplasmic dynein heavy chain (DHC) is encoded by the gene dync1h1 and
the peptide is ~532 kiloDalton in size. Cytoplasmic dynein heavy chain (DHC)
gene - dync1h1 is an essential gene. Animals with homozygous dynein null
mutations displayed embryonic lethality at embryonic day 8.5 where the embryo
development couldn’t proceed past the gastrulation stage due to disruptions in
Golgi trafficking and function (Harada et al., 1998). A single DHC monomer is
4646 amino acids long peptide in humans and 4644 amino acids long in mice.
The DHC can be divided into two main domains – N terminal tail domain and C
terminal globular head domain (Figure 1.2). Two monomers of DHC
homodimerize at the N-terminal tail region and interact with other subunits to
form a single functional unit of dynein. The C terminal globular head has 6
repeating AAA+ ATPase units forming a ring structure arrangement (Burgess et
al., 2004) (Sakato and King, 2004).
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Figure 1-3 Cytoplasmic Dynein Heavy Chain (DHC) peptide
Dynein heavy chain has two domains – N terminal tail domain and C terminal head
domain. There are also six AAA ATPase domains (AAA1-AAA6) that make up the motor
dynein ring.
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The six ATPase rings domains (AAA1-AAA6) are responsible for the motor
activity of DHC (Kon et al., 2012). Ring domain AAA1 has the p-loop motif that
can bind and hydrolyze ATP to generate energy for dynein motor activity
(Gibbons et al., 1991). Domains AAA2-AAA4 has p-loop motifs and ability to bind
ATP, whereas domains AAA5-AAA6 lack ATP binding sites. Overall, domains
AAA2-AAA6 lack ATP hydrolysis activity but do provide structural integrity and
regulate functions of the dynein motor ring (Mocz et al., 1991) (Neuwald et al.,
1999). A coiled-coil ‘stalk’ region is located between AAA4-AAA5 in the motor
ring and contains the microtubule binding domain (MTBD) of dynein heavy chain
at its tip (Koonce, 1997). ‘Linker’ domain lies across the six ATPase rings and it
changes its conformation based on the ATP binding state of dynein (Roberts et
al., 2012).
The cytoplasmic dynein undergoes a mechanochemical cycle where mechanical
conformational changes and chemical transitions regulate the motor activity. A
typical mechanochemical cycle of dynein consists of the following steps
(Burgess et al., 2003; Imamula et al., 2007; Kon et al., 2005) 1. In the initial state, dynein is attached to the microtubule track via the
microtubule binding domain (MTBD) in the stalk region.
2. When an ATP molecule binds to the AAA+ ATPase domain of dynein
heavy chain, the MTBD of the stalk detaches from the microtubule.
3. Detachment of stalk from the microtubule causes a conformational change
in the linker domain and linker gets rotated.
5

4. Upon ATP hydrolysis, MTBD of stalk binds to a new position on the
microtubule and that leads to the release of ADP and Pi (inorganic
phosphate molecule).
5. Released Pi causes linker domain to straighten and generate a
“powerstroke” that extends dynein tail along with its cargo to move further
along towards the minus end of the microtubule track.

1.2

Cytoplasmic Dynein Function

Dynein has variety of roles and functions to play in a healthy functioning cell.
Dynein is involved in both cell division and interphase activities of the cell. Dynein
moves its cargoes on the microtubule in a “stop and go” manner. If the same
cargo has dynein and kinesin attached to it, then the transport of the cargo can
momentarily stop and the travel direction can get switched sometimes from the
retrograde to anterograde direction inside the cell (Steffen et al., 1997).
Sometimes the role of dynein is also distinct in different organisms – for example,
dynein transports vesicles in filamentous fungi (Sivagurunathan et al., 2012)
whereas dynein is responsible only for mitotic spindle positioning in yeast (Moore
et al., 2009). Even viruses utilize dynein driven transport of endocytotic vesicles
to reach the nucleus to replicate itself using the host machinery (Dodding and
Way, 2011). These functions of dynein are broadly categorized and summarized
in Table 1-1.
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It is clear that cytoplasmic dynein is involved in many cellular functions that are
essential for the cell growth, maintenance, and survival. Total loss of dynein
function causes early embryonic lethality in Drosophila melanogaster (Dick et al.,
1996). Heterozygote dynein heavy chain knockout mice did not exhibit any
phenotype, however, the dynein-null homozygous mice were embryonic lethal
and did not survive past the gastrulation stage (Harada et al., 1998).
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Table 1-1 Cellular functions of cytoplasmic dynein
Category

Cargo
Vesicles

Cellular functions
Transport of vesicles

References
(Sivagurunathan et al., 2012),
(Koonce, 2000)

Early endosomes

Receptor sorting and Rab5 positive early

(Driskell et al., 2007)

endosome morphogenesis in HeLa cells

Organelle transport

Peroxisomes

Coordinated movement of peroxisomes in

(Kural et al., 2005)

cultured Drosophila melanogaster cells
Melanosomes

Regulation of melanosomes transport in

(Gross et al., 2002)

Xenopus melanophore cell line
Golgi vesicles

Transport of vesicles from endoplasmic

(Presley et al., 1997),

reticulum to Golgi in mammalian cell lines

(Hoogenraad et al., 2001)

Transport of mitochondria in motor axons of

(Pilling et al., 2006),

Drosophila melanogaster and in neurons

(Schwarz, 2013)

Lysosomes and

Rab7-interacting lysosomal protein (RILP)

(Jordens et al., 2001),

late endosomes

recruit dynein to Rab7 positive lysosomes and

(Cantalupo et al., 2001),

Mitochondria

late endosomes in mammalian cells
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Category

Cargo

Recycling and degradation

Phagosomes

Cellular functions
Dynein and dynactin regulate the maturation

References
(Blocker et al., 1997)

and minus end directed motility of phagosomes
in mammalian cells
Autophagosomes

Maturation of autophagosomes (containing

(Maday et al., 2012)

organelles and soluble proteins for targeted
degradation) is regulated spatially by dynein in
primary neurons
Aggresomes

Dynein drives the misfolded protein into

(Johnston et al., 2002)

aggresomes for sequestration and eventual

Cell division

degradation
Nuclear

Dynein positions nucleus in budding yeast

positioning

Saccharomyces cerevisiae during cell division

Spindle

Cortical dynein pulls and displaces microtubules

positioning

for mitosis and meiosis

Centrosomes

Dynein transports and assembles gamma

(Moore et al., 2009)

(McNally, 2013)

(Young et al., 2000)

tubulin and pericentrin at the centrosomes for
microtubule nucleation & organization
Chromosome

Dynein associated with the nuclear envelope

separation

drives separation of chromosomes in prophase
9

(Raaijmakers et al., 2012)

Category

Cargo
Nuclear rotation

Cellular functions
Dynein rotates and directs the nucleus in the

References
(Levy and Holzbaur, 2008)

Cytoskeleton & protein transport

leading edge of motile fibroblasts
Microtubules

Dynein maintains stable microtubule and

(Varma et al., 2008)

kinetochore orientation for aligning
chromosomes during metaphase
Neurofilaments

Direct interaction and translocation of

(Shah et al., 2000)

neurofilaments by dynein in neuronal cells
Transcription

Retrograde transport of transcription factor such

factors

as glucocorticoid receptor from the cytoplasm to

(Harrell et al., 2004)

the nucleus
Ribonucleoprotein

Correct mRNA localization by dynein mediated

(Wilkie and Davis, 2001)

apical transport in Drosophila melanogaster

Viral transport

HIV‐1 and HSV1

Dynein is hijacked by the viruses such as

(Dodding and Way, 2011)

Human immunodeficiency virus type 1 (HIV‐1)
and Herpes simplex virus (HSV1) to reach the
nucleus of the host cells for replication
Adenovirus

Adenovirus capsid hexon directly interacts with
dynein for viral transport to the nucleus
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(Bremner et al., 2009)

1.2.1 Dynein interactions with its binding partners
There are three families of cytoskeletal motor proteins inside a cell – microtubulebased dynein, microtubule-based kinesin, and actin-based myosin. Multiple
subfamilies and isoforms of kinesins and myosin are available inside the cells to
perform distinct cellular functions (Vale, 2003). However, dynein has only three
classes inside the cell as mentioned previously – cytoplasmic dynein 1,
cytoplasmic dynein 2, and axonemal dynein. Cytoplasmic dynein 2 and axonemal
dynein are dedicated to ciliary and flagellar functions specifically. Therefore,
cytoplasmic dynein 1 (referred as dynein from now on) is solely responsible for
multiple cellular functions in all cell types besides cilia/flagella. It is no wonder
that dynein utilizes and interacts with various adaptor proteins to carry out
diverse cellular functions (Vallee et al., 2012).
Binding of dynein with its interacting partners controls different cellular functions
and is needed to load the cargo onto the motor complex. Dynein cargoes range
from membranous vesicles, organelles, proteins, cytoskeletal components and
even viruses. Furthermore, an active motor complex facilitates varied dyneinbased functions such are organelle transport and positioning (Burkhardt et al.,
1997), mitotic chromosome separation (Dujardin et al., 1998), and nuclear
migration (Levy and Holzbaur, 2008). Dynein interacts with many intracellular
binding partners via direct or indirect interactions (Figure 1-4). DHC participates
in the catalytic motor activity and other dynein subunits like LCs, ICs, LICs
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interact with adaptor proteins to regulate various dynein functions in the cell
(Pfister, 2015).
The direct binding partners of dynein include nuclear distribution protein E
(NudE) (McKenney et al., 2011), lissencephaly (LIS 1) (Huang et al., 2012),
dynactin (dA) (Schroer, 2004), RAB-interacting lysosomal protein (RILP)
(Schroeder et al., 2014), Huntingtin protein (Htt) (Caviston and Holzbaur, 2009),
Snapin on late endosomes (Cai et al., 2010), adenoviral hexon protein (Bremner
et al., 2009), and pericentrin centrosomal protein (Tynan et al., 2000).
Dynactin regulates dynein driven motility by enhancing dynein’s binding with the
microtubule and making the transport more processive (Culver-Hanlon et al.,
2006). Additionally, dynactin also acts as an cargo adaptor for dynein and helps
dynein link with multiple cargo adaptors such as - Ankyrin 2 (AnkB) on
membranous cargoes (Lorenzo et al., 2014), RILP on Rab7 positive late
endosomes (Jordens et al., 2001), c-Jun N-terminal kinase-interacting proteins
(JIPs) on neuronal cargoes (like amyloid precursor protein) (Fu and Holzbaur,
2013), Huntington-associated protein 1 (HAP1) on neuronal vesicles (Engelender
et al., 1997), Spectrin on Golgi vesicles & late endosomes/lysosomes (Holleran
et al., 1996), bicaudal D/BICD2 on Golgi-ER vesicles (Liu et al., 2013; Matanis et
al., 2002), and TRAK/Milton adaptor proteins on mitochondria (van Spronsen et
al., 2013).
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DHC

DLIC
Htt, Snapin

DIC

Direct interaction with dynein

Lis1

Indirect interaction with dynein

Adenoviral hexon protein, pericentrin, RILP,

DIC

Dynactin

DLC

NudE/NudEL

BicD, RILP, JIP, HAP1, AnkB, Spectrin, TRAK/Milton
Lis1

Figure 1-4 Binding partners of dynein
Dynein interacts with various cargo adaptors either directly (shown in blue arrows) or indirectly (shown in orange arrows) to
achieve versatility in its cellular functions. Dynein heavy chain (DHC), dynein light intermediate chain (DLIC), dynein
intermediate chain (DIC) and dynein light chain (DLC).
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1.2.2 Dynein mutations linked to neurodegeneration in humans
Neurons are highly polarized cells with axonal projections as long as up to a
meter in length. Consequently, it is understood that neurons need robust axonal
transport for survival. Dynein has an established role in retrograde transport of
cargoes from the neuronal tip to soma in neurons (Perlson et al., 2010).
Additionally, dynein interacts with dynactin to form a highly processive motor
complex (Culver-Hanlon et al., 2006) that has an important role in axonal
transport (Waterman-Storer et al., 1997). The dynein/dynactin motor protein
complex transports cargo from the tip of the axon towards the neuronal cell body
(retrograde direction). Other functions of dynein in neurons includes growth and
development of neurites (Barakat-Walter and Riederer, 1996), formation of
synapse in neurons (Cheng et al., 2006), axonal transport of microtubules &
neurofilaments (He et al., 2005) and intracellular organelles (Schnapp and
Reese, 1989), and neuronal migration inside the cortical layer of the brain
(Sasaki et al., 2000).
Seeing how crucial dynein is for neuronal growth and maintenance, it would not
seem very surprising to see a dynein heavy chain mutation leading to
neuropathies in humans (figure 1-5). The first dynein heavy chain mutation
H306R was reported in 2011, that lead to a hereditary motor-sensory
neurodegenerative disease called Charcot Marie Tooth Disease Type 2O in
humans (Weedon et.al. 2011). Since then at least 17 genetic mutations spanning
the motor and tail domains of the dynein heavy chain have been identified in
14

neurodegenerative diseases in humans (summarized in Table 1-2). The reported
dynein heavy chain mutation related diseases in humans can be broadly
classified as motor-sensory neuropathies, central nervous system deficits, and
congenital defects.
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Figure 1-5 Mutations in Dynein Heavy Chain (DHC)
Mouse mutations (top, in blue text) and human mutations (bottom, in red text) in the DHC peptide. Mice mutations are
reported in the tail domain of the DHC peptide, whereas the human mutations span the entire length of the DHC peptide.
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Table 1-2 Dynein heavy chain mutations in humans
Disease
Charcot Marie Tooth

DHC mutation

Clinical symptoms

H306R

Type 2O (CMT2O)

Reference

muscle weakness and wasting, gait

(Weedon et al.,

abnormalities, skeletal deformities,

2011)

motor milestone delays, loss of
sensation
Spinal Muscular Atrophy

I584L, K671E, Y970C,

Severe muscular atrophy in legs,

(Harms et al.,

– Lower Extremity

G1132E

loss of motor neurons, delay in

2012)

Dominance (SMA-LED)

motor milestones, waddling gait

Malformation of Cortical

deletion 659-662, K129I,

Neuronal migration defects in

Development

K3336N, R3384Q, R1567Q, cerebellar cortex, microcephaly or
R3344Q, R1962C, K3241T,

macrocephaly, polymicrogyria,

R3344Q

epilepsy/seizure in severe cases
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(Poirier et al.,
2013)

Disease
Intellectual disability

DHC mutation

Clinical symptoms

E1518K, H3822P

Reference

Defects in neuronal migration,

(Willemsen et al.,

cortical development malfunctions,

2012)

impaired speech, reduced
intellectual and mental functions,
gait problems
Congenital cataracts and

R2332C

gut dysmotility

Cataract at birth, oral dysphagia,

(Gelineau-Morel

dysmotility in gut, developmental

et al., 2016)

milestone delay, bifrontal
polymicrogyria

18

It is interesting to note that even though these mutations lie in the same DHC
gene, they result in different clinical manifestations in humans. The DHC motor
domain mutations generally lead to cortical development type of defects,
whereas, the DHC tail domain mutations were observed to cause motor-sensory
type of defects in the reported human neuropathies. Moreover, it is important to
note that all dynein mutations in humans exhibit symptoms that are heavily
related to neuronal defects rather than any other type of defects in humans. This
suggests that dynein must have a specialized role in the neurons because even
the smallest single point mutation in dynein can disrupt the regular functions of
the central or peripheral nervous system. Hence, it is evident that mammalian
neurons must be particularly sensitive to the dynein mutations.

It would be

valuable to understand how dynein heavy chain mutations cause diseases
specifically of the nervous systems in humans.
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1.3

Charcot-Marie-Tooth Diseases in Humans

Charcot-Marie-Tooth (CMT) disease is the most common type of hereditary
motor-sensory neuropathy in humans with estimated prevalence rate is 1 in 2500
humans. CMT is characterized by symmetric distal limb weaknesses, muscular
atrophy in hands and/or feet, loss of sensation in lower limbs that may lead to
foot ulcerations, and skeletal defects like pes cavus (high arching of feet) (Figure
1-6).
More than 80 genes that are involved in neuronal structure maintenance signal
transduction, and axonal transport are reported to have mutations that are linked
with CMT (Bird, 1993). CMT patients are categorized into different types (table 13) based on their nerve conduction velocity (NCV) and family history-based
inheritance of the disease. In each category, letters are assigned to represent the
gene involved. For example – CMT1A, CMT1B, CMT1C and so on, CMT2A,
CMT2B, CMT2C and so on. CMT1A indicates CMT Type 1A which is caused by
a mutation in PMP22 gene (myelination gene) (Patel et al., 1992) whereas
CMT1B indicates CMT Type 1B which is caused by a mutation in MPZ gene
(another myelination gene).
CMT is clinically diagnosed by molecular genetic testing and by identifying
peripheral neuropathy symptoms during their physical examinations and in their
previous medical history. CMT has a variable onset in patients, ranging from as
early as age at birth to as late as age 50. Currently there is no cure for CMT, and
the treatment is based on the clinical symptoms presented by the patients. CMT
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patients often have to rely on surgical treatments, physical therapy, and use of
prosthetics like crutches/ankle braces to cope with the symptoms. About 5% of
all CMT patient are dependent on wheelchair for mobility.
Another challenge with CMT is the heterogeneity of the disease onset,
progression, and clinical symptoms even in related patients from the same family
pedigree. For example- in the Dominant Intermediate Charcot-Marie-Tooth
disease (DI-CMT), some patients from the same family may show demyelination
associated symptoms, whereas other patients from the same family may show
axonal degeneration, and some may even show both demyelination and axonal
demyelination form of the CMT symptoms.

Figure 1-6 Clinical symptoms associated with Charcot Marie Tooth (CMT)
CMT patients primarily show distal lower limb muscle wasting and atrophy, foot
deformity (pes cavus), foot ulcerations, and gait abnormalities.
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Table 1-3 Types of Charcot-Marie-Tooth disease in humans
Type of CMT

Type of defect

Inheritance

Some examples of mutations (Bird, 1993)
PMP22, MPZ, LITAF, ERG2, NEFL

CMT Type 1

Demyelination with

Autosomal

(most common)

reduced NCV of <35m/s

dominant

CMT Type 2

Axonal degeneration with

Autosomal

MFN2, RAB7, TRPV4, GARS, NEFL, MPZ,

normal NCV>45m/s

dominant

DYNC1H1, GDAP1, HSPB8, LRSAM1, MORC2,

DI- CMT

Demyelination and axonal

Autosomal

GDAP1, MPZ, DNM2, DRP2, GNB4, INF2,

(Dominant

degeneration with NCV of

dominant

PLEKHG5, YARS,

Intermediate)

35-45m/s

CMT Type 4

Demyelination and axonal

Autosomal

GDAP1, MTMR2, SBF2, SH3TC2, NDRG1,

(rare)

degeneration with NCV of

recessive

EGR2, PRX, FGD4, FIG4, HINT1

X-linked

DNM2, MPZ, YARS, GJB1

35-45m/s
CMT Type X

Demyelination and axonal
degeneration with NCV of
35-45m/s
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1.3.1 Dynein mutation linked to CMT2O and SMA-LED
A dynein heavy chain mutation linked to Charcot-Marie-Tooth type 2O (CMT2O)
in humans was first identified in 2011 (Weedon et al., 2011). Exome sequencing
of genes in a four generation European family identified a single point missense
substitution of Histidine to Arginine at position 306 (H306R) in cytoplasmic dynein
heavy chain 1 peptide (figure 1-7). The autosomal dominant H306R mutation
affected 23 members (male and female) in this family and they showed a varied
range of clinical symptoms.

Figure 1-7 CMT2O and SMA-LED linked mutation in dynein heavy chain
Missense substitution mutation (Histidine to Arginine) at position 306 in human
cytoplasmic dynein heavy chain peptide has been linked to two distinct neuropathies –
Charcot Marie Tooth type 2O (CMT2O) and spinal muscular atrophy with lower extremity
dominant (SMA-LED).

CMT2O patients with autosomal dominant heterozygous H306R mutation have
varied disease onset ranging from early childhood to early adulthood. CMT2O
patients reportedly had delayed motor developmental milestones, problems in
walking or running, recurrent falls, slow progressing muscle weakness and
muscle wasting in lower legs, and skeletal deformities pes cavus (high arching of
23

foot). Physiological tests with CMT2O patients revealed normal nerve conduction
velocities, evidence for axonal degeneration in sural nerve biopsies, and
denervation defects in muscle biopsies. Several patients that were severely
affected with CMT2O also reported to have neuropathic pain and prickling
sensation (paresthesia) in their lower limbs. A few patients also reported loss of
reflexes and sensation, speech delays & behavioral problems, lumbar lordosis,
spinal and hip issues leading to waddling gait, and loss of proximal muscles in
the upper back (periscapular weakness).
In parallel, an independent study of a Japanese family with the same H306R
mutation presented clinical symptoms that were consistent with spinal muscular
atrophy with lower extremity dominant (SMA-LED) (Tsurusaki et al., 2012). The
patients in this family showed clinical features that were different from CMT2O
patients, such as proximal lower limb weakness instead of distal limb weakness
and non-progressive nature of muscular atrophy/wasting. SMA-LED patients with
H306R mutation showed motor neuron disease involvement but not sensory
neuron involvement. It is interesting to note that a family member in the
European family with CMT2O showed proximal limb atrophy like SMA-LED
patients in this Japanese family. In conclusion, the single point mis-sense
substitution of H306R in cytoplasmic dynein heavy chain has been reported to
cause to two separate neuropathies in humans – CMT2O and SMA-LED.

24

1.4

Mouse Models with Neurodegeneration Linked Dynein Mutations

There are three reported mouse models with DHC mutations – Legs at odd
angles (Loa), Cramping (Cra), Sprawling (Swl) (figure 1-8). These mice were
named after their abnormal hind limb clenching phenotype and their posture.
Heterozygotes of all three mouse models had normal lifespan, whereas the
homozygotes showed severe phenotype & did not survive embryonically or after
birth (Chen et al. (2007); (Hafezparast et al., 2003).
Loa and Cra mice were generated independently via N-ethyl-N-nitrosourea
(ENU) treated mice and were identified due to abnormal clenching of hind limbs
when lifted by tail (Hrabe de Angelis et al., 2000). Swl was created via radiationinduced mutagenesis, also displayed abnormal clenching of hind limbs (Duchen,
1974). All three Loa, Cra, and Swl are autosomal dominant mutations that lead to
neurodegenerative phenotypes. Loa/+ and Cra/+ developed late-onset of motor
neuropathy,

whereas

Swl/+

showed

early-onset

of

hereditary

sensory

neuropathy. The key features of the three DHC mutant heterozygous mice are
listed below in table 1-4.
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Figure 1-8 Dynein heavy chain (DHC) mutations in mice
Mouse mutations in the DHC peptide are reported in the tail domain and are associated with Loa, Cra, and Swl mice.
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Table 1-4 Dynein heavy chain mutations in mice
DHC mutation

Phenotype

Legs at odd angles (Loa) –



Loa/Loa homozygous lethal

F580Y



late-onset motor neuron

(Hafezparast et al., 2003)

degeneration in Loa/+


gait abnormalities



reduced front and hind limb strength,



thinner dorsal root and sciatic nerve



abnormal proprioception & absence of
H-reflex



lumbar DRG neurons loss



mild loss of spinal α- motor neurons



muscle spindle loss



neuronal migration defects

Cramping (Cra) – Y1055C



Cra/Cra homozygous lethal

(Hafezparast et al., 2003)



late-onset sensory neuron
degeneration in Cra/+



gait abnormalities



reduced hind limb strength



thinner dorsal root



abnormal muscle pathology,

27



mild loss of spinal α- motor neurons



behavioral hyperactivity



mitochondrial dysfunction in skeletal
muscles

Sprawling (Swl) –



Swl/Swl homozygous lethal

[GIVT]1040[A]



early-onset hereditary sensory

(Chen et al., 2007)

neuropathy in Swl/+


gait abnormalities



reduced hind limb strength,



thinner dorsal root and sciatic nerve



abnormal proprioception & absence of
H-reflex



lumbar DRG neurons loss



muscle spindle loss

To better understand the role of dynein in neurodegeneration, Loa/+, Cra/+, and
Swl/+ heterozygote mice were separately cross bred with the mutant SOD1G93A
mouse model of amyotrophic lateral sclerosis (ALS). ALS is a fast progressing
neurological disease marked by progressive loss of motor neurons, leading to a
total paralysis and lethality 3-5 years after onset. The gain of function mutation
G93A in superoxide dismutase 1 (SOD1) is autosomal dominant and kills motor
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neurons rapidly (Valentine et al., 2005). It was interesting to note that when Loa/+
and Cra/+ were crossed separately with ALS SOD1G93A mice, their double
heterozygotes pups showed attenuation of the ALS SOD1G93A symptoms and
improved lifespan (Kieran et al., 2005) (Teuchert et al., 2006). This was a very
unsuspected finding and opposite of what was expected at the time. Loa/+ and
ALS SOD1G93A double heterozygotes also showed a remarkable increase in its
retrograde axonal transport. Swl/+ and SOD1G93A heterozygotes did not show any
attenuation or improvement of ALS SOD1G93A associated phenotype. It is
interesting to note that even though not all three mutations lie in the same tail
region of DHC, their attenuation response to ALS mutant SOD1G93A was the
same.
Undoubtedly, the three dynein heavy chain mutant mice (Loa, Cra, Swl) provided
many key insights into understanding the dynein function in neurodegenerative
disorders. However, Loa, Cra, and Swl mutations are not linked to any disease
alleles in humans and it is difficult to correlate their findings to human
neuropathies. Nevertheless, it would be very interesting to compare Loa, Cra,
and Swl mice studies with other DHC mice models that have dynein mutations
linked to an actual human disease.
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1.5

Peripheral Nervous System of Mouse

The peripheral nervous system of mouse comprises of nerves and ganglia
arising out of the spinal cord. The dorsal root ganglia (DRG) is a cluster of
sensory neuron cell bodies located in pairs in the spinal column of mice that start
forming in the embryo at embryonic day 13 (E13) (Lawson and Biscoe, 1979).
The sensory neurons located in the DRGs are pseudo-unipolar in nature and do
not have dendrites. The DRG sensory neurons have a single axonal projection
that branches into two – peripheral and central branches (figure 1-9). The
peripheral branch brings in the nerve impulses from the innervated tissues (skin
or muscle) to the neuronal cell body located in the DRG. The central branch
carries the impulse away from the soma to the central nervous system i.e. the
spinal cord or brain. Both branches are myelinated and carry the nerve impulses
towards the central nervous system (shown by the arrows in figure 1-9).

Figure 1-9 Pseudo-unipolar sensory neurons in DRGs
Sensory neurons in the Dorsal Root Ganglia (DRG) are pseudo-unipolar in nature, i.e. it
has one cell body and two functional axonal branches – peripheral and central branches.
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1.5.1 Role of dynein mediated retrograde signaling in sensory neurons
Growth and maturation of sensory neurons inside the DRGs are dependent on
various neurotrophic factors such as nerve growth factor (NGF), glial derived
neurotrophic factors (GDNF), brain derived neurotrophic factors (BDNF), and
neurotrophins (NTs) (Kimpinski et al., 1997) (Markus et al., 2002) (Klusch et al.,
2018). The neurotrophic factors are secreted by the target tissue (muscle, skin,
or visceral organ) and stimulate the development and function of sensory
neurons (figure 1-10).

Figure 1-10 Neurotrophic factors in sensory neurons development
Sensory neurons and motor neurons growth, maturation and survival depends on the
neurotrophic factors such as neurotrophins (NTs) and glial derived growth factors
(GDNF) released by the target tissue they innervate.

The neurotrophic factors bind to the tyrosine kinases (Trk) receptors located on
the axonal terminals of the peripheral branch of the sensory neuron (table). NGF
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specifically binds to TrkA receptors, NT4 and BDNF specifically bind to TrkB
receptors, and NT3 specifically binds to the TrkC receptors (figure 1-11).

Figure 1-11 Neurotrophic factors activate Trk signaling in neurons
Neurotrophic factors bind to a specific Trk receptor and activate downstream signaling of
neuronal maintenance and survival factors. NGF= Nerve Growth Factor, BDNF= Brain
Derived Neurotrophic Factors, NT3/4= Neurotrophins 3/4.

Binding of neurotrophic factors leads to dimerization of the receptors and their
autophosphorylation that recruits the effectors for downstream Trk signaling. The
activated Trk signals send survival factors such as mitogen-activated protein
kinase (MAPK); phosphatidylinositol 3-kinase (P13K); phospholipase (PLC-γ)
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etc. (Chao, 2003) (Delcroix et al., 2003) to the neuronal cell body located in the
DRG via dynein mediated retrograde transport (Heerssen et al., 2004) (Ito and
Enomoto, 2016).
Neurotrophin mediated retrograde signaling also facilitates differentiation and
specification of neuronal subpopulations in the peripheral nervous system of
mice. Studies with BAX-/- and TrkA-/- double mutant mice lacking the NGF
mediated TrkA signaling showed an absence of calcitonin gene related peptide
(CGRP) expressing neuronal subpopulation in the mice DRGs (Suzuki et al.,
2010). Other studies have explored and established the role of target derived
neurotrophic factors (such as neurotrophins & BDNF) in determining the
cholinergic/peptidergic

phenotype

of

the

sensory

neurons

during

their

development and differentiation in mice (Bergmann et al., 1997; Cellerino et al.,
1996).
Several in vitro studies have investigated and established the role and
importance of retrograde transport of neurotrophic factors. Neurotrophic factors
released by the target tissues bind to the specific receptors in the terminal ends
of the sensory axons innervating the tissue. Then the neurotrophic factors
mediated signaling cascade is activated at the axonal tip and it travels all the way
to the neuronal cell body in retrograde fashion.
Classical experiments with special compartmentalized cell chambers called
Campenot chambers were performed to investigate the spatial effect of
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neurotrophin Nerve Growth Factor (NGF) on axonal growth (Campenot, 1977).
First, NGF was only supplied selectively to the compartment in the Campenot
chamber that had distal ends of axons growing in it. It was observed that axonal
growth was maintained even though the neuronal cell bodies did not receive
NGF. However, when the NGF was applied only to the Campenot compartment
containing neuronal cell bodies, the distal axons started retracting and
degenerating.

These

key

experiments

established

that

NGF

mediated

neurotrophin signaling at the distal ends of neurons were required and adequate
for axonal growth and maintenance.
Subsequent studies then established that neurotrophins bound to the receptors
are internalized and packaged inside signaling endosomes for retrograde
transport to the neuronal cell bodies (Wang et al., 2016). Further investigation of
retrogradely transported signaling endosomes in rat sciatic nerves revealed that
these vesicles contained not only neurotrophin NGF and its receptor TrkA, but
also characteristic markers of early endosomes such as early endosome antigen
1 (EEA1) and Rab5 (small G-protein) (Deinhardt et al., 2006). Additionally,
components of mitogen-activated protein kinase (MAPK) and phosphatidylinositol
3-kinase (P13K) pathways were also found inside the signaling endosomes. The
same study also showed the evidence of dynein dependent retrograde transport
of these NGF-TrkA containing endosomes by colocalization, biochemical, and
nocodazole microtubule disruption assays. Several other independent studies
have also established the role of dynein in retrograde transport of neurotrophic
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factors – colocalization of 14kDa Dynein Light Chain (DLC) with Trk receptors
(Yano et al., 2001), Rab7 positive vesicles in NGF-TrkA signaling (Saxena et al.,
2005), and p75 and TrkB signaling (Deinhardt et al., 2006).
In conclusion, dynein dependent retrograde signaling is necessary for the
development, specification and maintenance of sensory neurons and it is not
surprising that dynein disruption could cause sensory neuropathies. Numerous
studies have shown that disrupted neurotrophic factor mediated Trk signaling
causes severe sensory neuropathies in mice (Smeyne et al., 1994) (Patel et al.,
2000) (Sleigh et al., 2017).

1.5.2 Sciatic Nerve anatomy in mice
The sciatic nerve is the largest nerve innervating the hind limbs of mice. The
sciatic nerves arise from the sciatic notch near the spine, then continues all the
way from lumbosacral region to popliteal fossa (knee cavity) where it splits into
peroneal, sural and tibial nerves to innervate the lower hind limbs in mice (figure
1-12). The majority of sciatic nerves in C57BL/6J strain mice are made up of the
third lumbar (L3) and fourth lumbar (L4) spinal nerves and a lesser contribution is
received from the fifth lumbar (L5) spinal nerve (Rigaud et al., 2008). The
percentage contribution from each spinal nerve in a sciatic nerve is roughly about
L3 (~28%), L4 (~56%) and L5 (~16%) and no spinal nerve contribution is
reported from L6 at all.
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Figure 1-12 Sciatic nerve anatomy in mice
Spinal nerves arising from lumbar vertebrae L3, L4, and L5 combine together to form a
sciatic nerve in mice that splits up into peroneal, tibial, and sural nerves to innervate the
lower hind limbs.

Because the sciatic nerve contains both motor and sensory neurons, it is also
regarded as a “mixed nerve” (Figure 1-13). Dorsal root supplies the sensory
neurons (afferent fibers) and ventral root (efferent fibers) supplies the motor
neurons at lumbar L3, L4, and L5 in mice to make up the “mixed” sciatic nerve in
mice. The sensory nerves bring in the afferent sensing signals from the periphery
target tissue to the spinal cord for processing. Sensing signals can be sensing
temperature, pain stimulus, touch, vibrations etc. In contrast, the motor neurons
send out the efferent action signals from the spinal to the target tissues. Action
signals can be voluntary or involuntary action of a muscle group to a stimulus.
Knee jerk test is a classic example of a reflex arc where the reflex hammer hits
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the knee (stimulus) and the body reacts quickly by moving your leg away (action)
through rapid involuntary muscle contraction.

Figure 1-13 Sciatic nerve is a mixed nerve
Sciatic nerve has both sensory and motor neurons and is called a “mixed nerve”. Both
dorsal and ventral roots supply spinal nerves to make up the sciatic nerve.

1.5.3 Dorsal Root Ganglia anatomy in mice
Neural crest migration gives rise to a cluster of sensory neurons called dorsal
root ganglia (DRG). There are 62 DRGs in total and they are located in pairs
along the spinal cord – 8 pairs in cervical, 13 pairs in thoracic, 6 pairs in lumbar
and 4 in sacral region in the C57BL/6J strain of mice (Malin et al., 2007). There
are many types of heterogeneous somatosensory neuronal subpopulations
present in the DRGs- nociceptors, mechanoreceptors, thermoreceptors, and
proprioceptors (table 1-4). Somatosensory neurons transmit sensory signals to
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the spinal cord and brain from the target tissues that they innervate such as
muscle spindles, skin, and organs (Liu and Ma, 2011).
Table 1-5 Major types of somatosensory neurons in the DRG
Type of the neuron

Size of the fiber

Stimulus received

Nociceptors

Small diameter (c-fibers)

Pain stimulus

Mechanoreceptors

Medium diameter (Aδ-

Pressure, touch and

fibers)

vibration

Small diameter (AΔ-fibers)

Temperature (cold

Thermoreceptors

and warm)
Proprioceptors

Large diameter (Aβ-fibers)

Muscle stretch and
orientation

Different somatosensory neurons express different types of receptor. Nociceptive
neurons have small sized diameter axons and express the TrkC receptors for
Nerve Growth Factor (NGF) (Suzuki et al., 2010). In addition, peptidergic
nociceptive neurons express calcitonin gene-related peptide (CGRP), whereas,
non-peptidergic nociceptive neurons express IsolecithinB4 (IB4) on its plasma
membrane (Bennett et al., 1996). Chemical stimuli such as capsaicin have been
reported to also stimulate responses in nociceptors expressing capsaicin
receptors called transient receptor potential cation channel subfamily V member
1 (TRPV1) channels (Amaya et al., 2004). Proprioceptive neurons have large
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sized diameter axons and express TrkC receptors for neurotrophin 3 (NT-3)
uptake.
It is highly common for researchers to investigate the neuronal subpopulations in
the DRGs of mice exhibiting any sensory neurodegenerative symptoms. For
example - in sprawling (Swl) mice, it was reported that the heterozygous Swl/+
mice showed specific loss of its proprioceptive neurons and not in the nociceptive
neuron population in the lumbar dorsal root ganglia (Chen et al., 2007). As a
result, Swl/+ mice showed the corresponding phenotype of early-onset of
proprioceptive sensory neurological defects. In conclusion, investigation of sciatic
nerve anatomy and DRG neuronal subpopulation can provide key insights in
understanding molecular mechanisms behind sensory neuropathies.
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CHAPTER 2: MATERIALS AND METHODS
2.1

Generation of H304R mouse model

The knock-in H304R mouse model was generated using gene targeting in mouse
embryonic cells (figure 2.1). Using 3-step PCR mutagenesis, the CMT2O disease
linked dynein mutation (CAC to CGC at position 304) was introduced in the
targeting vector with Neo cassette. Presence of the mutation was confirmed by
sequencing the PCR amplified targeted region. Then embryonic stem cells were
electroporated to take in the targeting vector. Embryonic stem cell clones with the
correct targeted single point mutation were confirmed using resistance selection
markers, PCR screening, and southern blot analysis. The embryonic stem cells
were then microinjected in C57BL/6 mouse blastocysts and implanted into
psuedopregnant foster host female mice. The offspring chimeric mice were
obtained, and cross bred to yield the heterozygous knock-in founder mice. Four
heterozygous founder mice with the desired single point mutation in dynein
heavy chain were outcrossed with B6129SF2/J mice (Jackson laboratories) to
produce a colony of different lineages. Heterozygous male and female mice from
different lineages were bred to obtain homozygous litters of mice.
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Figure 2-1 Generation of knock-in H304R mouse model
Knock-in H304R mouse model was generated by introducing Neo cassette flanked
targeting vector that was microinjected into embryonic stem cells. Chimeric mice were
selected to obtain founder heterozygous knock-in founder mice.
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2.2

Mouse colony maintenance

2.2.1 Mouse colony housing
All mice related procedures were carried out with the University of Central
Florida’s Institutional Animal Care and Use Committee (IACUC) guidance and
approval. The mice were checked daily by the trained vivarium staff and were
immediately treated in case of any health issues. Mice were housed in clear
plastic cages lined with sanitized bedding and were provided ad libitum access to
clean food and water. Mice cages were also provided with red colored housing
tube and a wooden block for enrichment of their surroundings. The cages were
kept in an environment-controlled room at 22 ± 2 °C and atmospheric humidity of
50 ± 10%. Mice were exposed to artificial light from 7:00am-7:00pm and to
darkness at 7:00pm-7:00am on a 12-hour diurnal light cycle.
2.2.2 Mouse colony breeding
Heterozygous H304R mice were repeatedly outcrossed to the B6129SF2/J mice
(Jackson Laboratories, stock#101045). Mice pups remained with their mother for
nursing until they were weaned on post-natal day 21 (3 weeks of age). Tail snips
were collected from the 3-week old pups upon weaning for PCR based
genotyping. Mice tails were also tattooed with unique identification numbers
using Labstamp Tattoo system (Somark Innovations).
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2.2.3 Measurement of mouse body weight
Body weight of a mouse was recorded (in grams) every 2 weeks before the
mouse performed a behavior test. Bodyweight at 3 month of age were
statistically

compared

between

the

genotypes

(wildtype,

heterozygous,

homozygous) and gender (male and female) separately using One-way ANOVA
(GraphPad Prism 6.0 software).
2.2.4 Mouse health supervision
Mice colonies were kept under daily supervision of trained vivarium staff in case
any medical condition would arise. Mice were regularly monitored for their
posture, alertness, activeness, movement around their cages and consumption
of food and water. Physiological phenotypes of mice such as blood in urination,
and abscess on skins due to excessive scratching were immediately treated and
closely monitored. Mice teeth were routinely trimmed if they showed weight loss
due to inability to feed with longer teeth.
Other litter behaviors like fights with littermates, barbering each other, and
shredding of food were also noted. Phenotype like development of eye tumors,
recurrent seizures, and worsening health were also recorded. We immediately
euthanized any mice that showed any signs and symptoms of pain, suffering,
and unusual declining health.
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2.3

Behavioral phenotype characterization test

All three groups of mice (wildtype, heterozygous H304R/+, homozygous
H304R/R) performed behavioral tests every two weeks starting from 1 month of
age to 24 months of age or until death (whichever came first). Later time points
such as 15, 18, 21 and 24 months of the longitudinal study yielded similar
phenotypic trend in mice at 12 months of age. Hence, the test readings until 12
months only were averaged in a 3-month bin to give time points of 3 month, 6
month, 9 month, and 12 month for data analysis.
The behavior assay data was collected by the researchers that were blinded to
the genotype of the H304R mice. Mice were genotyped by other lab members
and the mice genotypes were revealed after the completion of the study for data
grouping and statistical analyses. Both testers alternated their turn in testing the
same test mouse every two weeks. The behavior tests - tail suspension, grip
strength, rotarod, and tail flick tests were performed on all three groups of H304R
mice (wildtype, heterozygous, homozygous) as described below.

2.3.1 Tail suspension test
The tail suspension test was performed to assess the postural reflex phenotype
of mice. A mouse was gently lifted by its tail and its positioning of hind limbs were
categorized as 'typical' or 'atypical' tail suspension reflex. In a 'typical' tail
suspension reflex (figure 2-2), the mouse splayed its hind limbs away from the
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body after being suspended by its tail. Whereas, in 'atypical' tail suspension
reflex, the mouse clenched its hind limbs tightly near its body when suspended
by its tail. The data was collected and recorded from two views (ventral and
dorsal) of the mice to get a better evaluation of the phenotype.

Figure 2-2 Tail suspension test
Mouse is gently suspended by its tail and the hind limb response is categorized as
typical (shown here) or atypical (hind limbs clenching together).

The percentage of mice displaying ‘atypical’ reflexes was calculated for all three
groups of mice (wildtype, heterozygous, homozygous) at each time point - 3, 6,
9, and 12 months. Then the ‘atypical’ reflex data were statistically compared
between the wildtype and heterozygous H304R/+ and between wildtype and
homozygous H304R/R mice at each time point using the Fisher’s exact test (twotailed distribution, p<0.05) on the GraphPad Prism 6.0 software.
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2.3.2 Grip strength test
A standard grip test was used to measure the muscular limb strength in mice
using a grip strength meter from Harvard Apparatus (BIOSEB GS3# 76-1068). All
limbs or front limbs of mouse were placed on the metal grid attached to the
readout equipment. Then the mouse was gently pulled across the metal grid
using its base of the tail. The equipment recorded the maximum force exerted (in
grams) by the all limbs or front limbs of the mouse being tested (figure 2-3).

Figure 2-3 Grip strength test meter
Grip strength in limbs is measured using a standard grip strength meter that records the
maximum force exerted by the mouse.

A test mouse performed 4 consecutive trial each of all limbs and front limbs grip
test. The 4 trials were averaged for all limbs and front limbs respectively to yield
one single readout each on a test day. Next, the averaged all limbs grip strength
readings and the averaged front limbs grip strength readings of a mouse were
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combined per each genotype at 3-month time intervals - 3, 6, 9, and 12 months.
The all limbs and front limbs grip strength data were statistically compared
between the wildtype and heterozygous H304R/+ and between wildtype and
homozygous H304R/R mice at each time point using Student’s t-test (two-tailed
distribution, p<0.05) on the GraphPad Prism 6.0 software.
2.3.3 Rotarod performance test
Rotarod test is a standard test used to measure motor coordination, muscle
endurance, and motor balance in mice. We performed rotarod test on our
wildtype, heterozygous, and homozygous mice cohorts using rotarod equipment
from IITC Life Sciences (model# 755). The optimized test parameters were input
into the equipment console and 5 mice were placed individually on a stationary
rod inside 5 different lanes before the start of the test (figure 2-4).

Figure 2-4 Rotarod machine to measure motor coordination
Motor coordination in mice is measured by the rotarod performance test. Five
mice can simultaneously run on the rotating rod to perform the rotarod
performance test.
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The rotarod started rotating at 5 RPM (Revolutions Per Minute) and gradually
ramped up to 40 RPM in 60 seconds and stayed constant for next 120 seconds
(figure 2-5). The entire run duration of rotarod was 180 seconds including 60
seconds of ramp time followed by 120 seconds of constant RPM. The equipment
recorded a mouse's fall on the plate below the rod during the 180 seconds total
rotarod run window.

Figure 2-5 Rotarod test profile
The rotarod machine starts at 5 RPM and then ramps up to 40 RPM in 60 seconds.
Then it stays at 40 RPM for rest of the rotarod test duration.

A mouse's fall on the plate triggered the magnetic switches at the bottom of the
plate and accurately detected and recorded the latency of fall (in seconds).
Software Series 8 was provided with the equipment and it was used to record the
latency of fall for the mice being tested. Each mouse performed three
consecutive trials of the rotarod test, and all three latency of fall readings were
averaged to yield a single test readout for a mouse at a time point. Next, the
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averaged latency of fall readings per mouse in the three groups of mice
(wildtype, heterozygous, and homozygous) were combined respectively at 3month time intervals - 3, 6, 9, and 12 months. The rotarod data were statistically
compared between the wildtype and heterozygous H304R/+ and between
wildtype and homozygous H304R/R mice at each time point using Student’s ttest (two-tailed distribution, p<0.05) on the GraphPad Prism 6.0 software.
2.3.4 Tail flick test
Tail flick test was used to quantify the pain sensitivity response of H304R mice to
thermal pain stimulus using Panlab tail flick meter (Harvard Apparatus #
LE7106). A mouse is placed in the restrainer provided with the equipment and
allowed to get habituated inside the restrainer for 2 minutes. Then the mouse tail
is placed under a beam of thermal light and the meter records the time (in
seconds) taken by the mouse to move its tail away from the source of thermal
pain stimulus. Tail flick test data was collected and compared between 1, 3 and
12 month wildtype, heterozygous H304R/+, and homozygous H304R/R male
mice.

Figure 2-6 Tail flick meter
Sensitivity and response to thermal pain stimulus in mice is measured by tail flick meter.
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2.4

Mouse dissections (sciatic nerve and dorsal root ganglia)

Tissue from the peripheral nervous system of mice was dissected out by surgical
procedures. Sciatic nerves and the dorsal root ganglia were collected from mice
of 3 month and 12 months of age.
2.4.1 Tissue harvesting and cryopreservation
Mice were euthanized by administering CO2 and cervical dislocation. Sciatic
nerve and lumbar dorsal root ganglia (DRG) samples were collected from both
left and right side of the mice using Leica S8 AP0 Stereo Microscope. Collected
tissue was fixed in 4% paraformaldehyde solution (EMS catalog#15710) for 30
minutes at 4°C. Then the tissue was left in 30% Sucrose solution (weight/volume)
overnight at 4°C. Next day, the tissue samples were embedded in labelled
histology molds (Ted Pella, Inc. catalog # 27118) containing Tissue-Tek® O.C.T.
Compound (Sakura Finetek USA Inc. catalog #25608-930). The tissue samples
were rapidly frozen on dry ice and stored at -80°C in labelled freezer boxes.
2.4.2 Cryosectioning and immunohistochemistry of tissue samples
Frozen sciatic nerve or lumbar DRG was cryosectioned in 10µm size thin
sections on Leica Cryostat (model# CM 1850) and collected on glass slides. The
samples were then washed in 1X PBS (Gibco) thrice for 5 minutes each to clean
away any O.C.T compound around the tissue. Waterproof boundaries were
drawn around each tissue sample with ImmEdge Hydrophobic Barrier PAP Pen
(Vector laboratories, catalog #H-4000). The tissue was permeabilized for 10
minutes with permeabilization buffer (0.5% Triton-X100). Then block buffer (10%
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normal goat serum and 0.1% Triton-X100 in PBS) was added for 60 minutes on
the samples. Tissue samples were incubated with appropriate dilutions of
primary antibodies (table 2-1) overnight at 4°C. Next day, the primary antibodies
were washed with block buffer twice and then incubated with respective
secondary antibodies for 2 hours at the room temperature. Unbound antibodies
were washed with block buffer twice, followed by 1X PBS wash twice. The tissue
samples were then mounted with ProLong™ Gold Antifade Mountant with DAPI
(ThermoFisher Scientific, catalog# P36931) and sealed with a glass coverslip.
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Table 2-1 Antibodies used for tissue immunohistochemistry
Primary antibody

Labels

Catalog number

Dilution
used

Mouse monoclonal Neuronal soma
to Beta-III tubulin

Abcam # 78078

1:200

Abcam # 40390

1:200

and axons

(βIII tubulin)
Rabbit polyclonal

Myelinated axons

to Myelin Basic
Protein (MBP)
Secondary

Labels

Catalog number

antibody

Dilution
used

Rabbit polyclonal

Perineurial glial

Abcam # 15309

1:200

to Glucose

cells in the sciatic

Transporter-1

nerve’s

(GLUT-1)

perineurium

Alexa Goat anti

Against mouse

ThermoFisher

1:200

mouse conjugated

antibodies

Scientific # A11001

Alexa Goat anti

Against goat

ThermoFisher

rabbit conjugated

antibodies

Scientific # A110035

with 488

with 546
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1:200

2.4.3 Microscopy and data analysis
Images of sciatic nerve and dorsal root ganglia tissues were captured on the
Leica M205 FA Fluorescence Microscope with Leica DFC3000G CCD camera.
The microscope settings and configurations were kept uniform between all the
samples to avoid variability (table 2-2).
Table 2-2 Microscopic settings used for imaging
False color

Wavelength

Exposure

(nm)

time

Green

515 nm

Red
Blue
Transmittance

Gain

Intensity

Magnification

139 ms

2.5x

60%

80X

660 nm

139 ms

2.5x

40%

80X

440 nm

2.6 sec

2.5x

100%

80X

none

139 ms

2.5x

45%

80X

Collected sciatic nerve images were then analyzed on the ImageJ software
(National Institutes of Health and the Laboratory for Optical and Computational
Instrumentation) to calculate the cross-sectional area of the nerve. Threshold
function was used to trace out the boundary of the nerve that was stained by the
perineural marker GLUT-1 antibody. The area inside the traced-out threshold
was measured using the ‘measure area’ function. The measured area (in mm 2)
was collected and compared between the wildtype, heterozygous H304R/+, and
homozygous H304R/R mice.
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2.5

Motility analysis studies in primary H304R neurons

Primary neurons from the embryonic brains of H304R mouse model were
dissected out and grown in vitro. Intracellular motility parameters were recorded
in in vitro primary neurons to characterize the functions of dynein in H304R
mouse model.
2.5.1 Tissue harvesting of embryonic primary neurons
Timed pregnancy breeding was set-up between the heterozygous male and
female mice. The embryos were removed at embryonic day 16.5 from a
euthanized pregnant female mouse. Brains were removed from each embryo and
were dissected further to collect the cerebellar cortex and hippocampus from
each lobe of the brain. Leica S8 AP0 Stereo Microscope was used for embryonic
dissections. Cortices and hippocampi of wildtype, heterozygous (H304R/+), and
homozygous (H304R/R) were then pooled together respectively after the
genotype of the embryos was determined by the PCR based method. Cortical
and hippocampal neurons were isolated respectively by enzymatic digestion
technique with Papain (Worthington® Biochemical Corp# LS003118) and DNase
(Worthington® Biochemical Corp # LK003172) in Hibernate® E minus
Ca2+/Mg2+ media (BrainBits® # HECAMG500). Neurons were plated on
0.3µg/ml poly-D-Lysine (Millipore Sigma) and 10µg/ml Laminin (ThermoFisher
Scientific # 23017-015) coated 25mm Fisherbrand® glass coverslips (Catalog #
12-545-102) in 6-well plates. The neurons were incubated at 37°C in warm
Neurobasal™ media (ThermoFisher Scientific # 21103049) supplemented with
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100X Antibiotic-Antimycotic (Gibco™ # 15240062), 50X B-27™ Supplement
(Gibco™ # 17504044), and 100x GlutaMAX™ (Gibco™ # 35050061). The
neurons were half fed by removing and replacing half of the media with fresh
neuronal media every other day.
2.5.2 Live neuronal imaging with Rab7-GFP labeled vesicles
Cortical neurons of all 3 genotypes (wildtype, heterozygous (H304R/+),
homozygous (H304R/R)) were nucleofected with Rab7-GFP plasmid using
standard protocol on the Nucleofector™ 2b Device (Lonza # AAB-1001). The
nucleofected neurons were then plated on the glass coverslips and incubated at
37°C in warm NeurobasalTM media (ThermoFisher Scientific # 21103049). The
nucleofected neurons were half fed with fresh media every other day.
Live neuronal movies were captured on the Nikon® Eclipse Ti Inverted
Microscope with Photometrics® Evolve EMCCD camera (#512) at D.I.V 10. The
live cell movies were recorded using the Metamorph® Automation and Image
Analysis Software (Molecular Devices). The movies were made at 100x
magnification with 500 frames captured at the frame rate of 10 fps (frames per
second) with the appropriate green fluorescence filter cube. The longest visible
projection of the neuron was selected visually and was used for making neuronal
movies to capture the motility events inside the neuronal projections.
Motility analysis on movies of neurons containing Rab7-GFP labeled vesicles
was done using the Kymograph function of the Metamorph® image analysis
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software (Molecular Devices) and described in the next section. Motility
parameters of Rab7-GFP labeled vesicles such as total number of movements,
run length (µm), run velocity (µm/sec), and the direction of vesicular movement
were calculated (figure 2-7). Motility data from different genotypes (wildtype,
heterozygous (H304R/+), homozygous (H304R/R) were compared using oneway ANOVA test on the GraphPad Prism®6 software.
Kymograph analysis description
The following Figure 2-7 is provided to illustrate the various features of
kymographs. For this purpose, a hypothetical set of two vesicles is shown.
Stationary vesicle is shown as a blue circle and a moving vesicle is shown as a
red circle inside a cell (figure 2-7). The red vesicle is shown moving on a
microtubule track shown with an orange line and the red vesicle is moving from
point B to A. A kymograph line is drawn from the cell center to the periphery
shown in the black line. The kymograph analysis of the black line is shown on the
right in the form of a time (sec) vs distance (µm) graph. The blue stationary
vesicle that does not move has a constant line as shown in blue indicating zero
displacement on the time vs distance graph. In contrast, the red vesicle that
moves shows the displacement as a slant line indicating a “run” on the time vs
distance graph. The slope of the slant line gives the run velocity (µm/sec) and the
slope angle gives the direction of the movement (towards or away from the cell
body).
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Figure 2-7 Schematic diagram of motility analysis using kymographs
Kymograph is a time vs distance graph generated to analyze the motility
parameters on vesicles (blue circle = stationary vesicle, red circle = moving
vesicle in motion).
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2.5.3 Live neuronal imaging with Synaptophysin-RFP labeled vesicles
Cortical and hippocampal primary neurons were each infected with Bacmam
Synaptophysin RFP (2µl/ml) (ThermoFisher Scientific # C10610) and incubated
for 48 hours. Live neuronal movies were captured as mentioned in the sections
above. Motility analysis of neurons containing Bacmam Synaptophysin RFP
labeled vesicles was done using the Kymograph function of the Metamorph®
Automation and Image Analysis Software

(Molecular Devices). Motility

parameters of Synaptophysin RFP positive vesicles such as total number of
movements, run length (µm), run velocity (µm/sec), and the direction of vesicular
movement were calculated. Motility data from different genotypes of mice
(wildtype, heterozygous (H304R/+), homozygous (H304R/R)) were compared
using one-way ANOVA test on GraphPad Prism®6 software.
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CHAPTER 3: BEHAVIORAL PHENOTYPE CHARACTERIZATIONS
OF H304R MICE

3.1

Introduction

Prior to our study, three other dynein heavy chain mutant mice were reported in
the literature – legs at odd angle (Loa), Cramping (Cra), and Sprawling (Swl).
Loa and Cra mice were generated using ENU-mediated mutagenesis (Hrabe de
Angelis et al., 2000) and Swl was created using radiation induced mutagenesis
(Duchen, 1974). All three mice displayed abnormal posture and hind limb
clenching during the tail suspension. These transgenic mice were considered to
be the paradigm mouse models of neurological dysfunction and were extensively
studied. Some of the phenotypic studies on Loa, Cra, and Swl mice are outlined
below.
A

multi-stage

protocol

called

SHIRPA

(Smith/Kline/Harwell/Imperial

College/Royal Hospital/Phenotype Assessment) was used to quantitatively asses
the phenotype of the Loa mouse in a longitudinal study (Rogers et al., 2001). The
Loa/+ test results were compared with age and gender matched wildtype control
mice in the behavioral and functional assessments done from 1 to 16 months of
age. During the SHIRPA screening, the heterozygote Loa/+ and wildtype mice
were assessed on tail suspension, grip strength, wire maneuver, and limb tone at
1, 3 and 14-16 months age.
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For grip strength testing, mice were gently pulled across a steel mesh grip and
the grip strength exerted was recorded qualitatively with arbitrary scores: no
effort= 0, slight semi-effective effort= 1, moderate effective effort= 2, active
effort= 4, and unusual effective effort =5. For the wire maneuver test, mice were
suspended on a horizontal wire by their fore limbs and the efforts to bring their
hind limbs to the wire were scored as “falls immediately” to “active grip” with hind
limbs. Lastly, in the hind limb tone assessment, mice were restrained in the
supine position and their resistance to the pressure on the hind paws (plantar
side) was recorded as “slight” or “moderate” or “heavy” resistance. Overall, the
Loa/+ mice exhibited abnormal posture of hind limb clenching during tail
suspension, significant reductions in hind limb (median score of 1= slight grip),
reduced performance in the wire maneuver test (median score of 1= difficulty in
grasping with hind limbs), and deficits in hind limb tone (median score of 1= slight
resistance) as compared to the wildtype control mice.
For another stage of SHIRPA protocol, Loa/+ mice performed the rotarod test
and spontaneous locomotor activity test. For the rotarod test, the test mouse was
placed on a rotating rotarod and time when a mouse would fall off from a rotarod
was recorded. In locomotor activity test, a mouse was placed in a clear Perspex
activity cage fitted with infra-red signals, and the infra-red beam breaks induced
by the mouse locomotion was detected and recorded over a 30 minutes test
window. The Loa/+ mice had a significant reduction in its rotarod performance at
1, 3 and 16 months’ time points as they were unable to stay on the rotarod as
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long as the control wildtype mice. During locomotion test, the Loa/+ mice
interestingly showed more locomotor activity than the wildtype control mice. In
conclusion, the SHIRPA protocol of behavioral assessments provides a
comprehensive

methodology

for

documenting

progressive

neurological

dysfunction in mouse models (Rogers et al., 2001).
The other two DHC mutant mice – Cra and Swl were also characterized using
SHIRPA protocol for their neurological functions. Just like Loa/+ mice, both Cra/+
and Swl/+ mice displayed hind limb clenching during tail suspension, gait
abnormalities, no reductions in front grip strength, and significantly reduced grip
strength in hind limbs (Banks and Fisher, 2008; Chen et al., 2007). The
homozygous Loa/Loa, Cra/Cra, and Swl/Swl mice were either embryonically
lethal or did not survive 24 hours post birth due to their inability to feed (Chen et
al., 2007; Hafezparast et al., 2003). Overall, the DHC mutant Loa, Cra, and Swl
mice models provided some interesting evidences in the role of dynein in
neurological dysfunction.

3.2

Rationale

The mutagenesis generated Loa, Cra and Swl mice have provided many key
insights in understanding the dynein function, however, the mutations in Loa
(F8580Y), Cra (Y1055C), and Swl ([GIVT]1040[A]) are not linked to any
neurodegenerative disease alleles in humans. It is hard to correlate their key
findings in understanding the dynein function in the context of neurodegenerative
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diseases in humans. Discovery of the first dynein mutation (H306R) in human
neuropathy (CMT2O) was an opportunity to study dynein function. Hence, we
generated the novel H304R mouse model as a tool to understand the dynein
function and mechanism in human neurodegenerative diseases.
The H304R mouse model has a mutation in its dynein heavy chain that is
reported to lead to human neuropathies such as Charcot-Marie-Tooth Type 2O
disease (CMT2O) and Spinal Muscular Atrophy with Lower Extremity Dominant
(SMA-LED). Both CMT2O and SMA-LED patients exhibit similar clinical
symptoms such as they display lower limb weaknesses, muscle wasting, skeletal
and joint deformities of foot, joint contractures, and problems in walking. CMT2O
patients also show a loss of sensation symptoms in addition to their motor
defects. The disease linked Histidine to Arginine substitution mutation is at
position 306 in the human dynein heavy chain, and the corresponding mutation is
at position 304 in mouse dynein heavy chain (Figure 3-1).

Figure 3-1 Comparison of dynein heavy chain peptide
CMT2O disease linked mutation is a missense substitution of Histidine (H) to Arginine
(R) at position 306 in human dynein heavy chain peptide. The corresponding mutation is
at position 304 in mouse dynein heavy chain peptide.
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We generated the novel H304R mouse model using knock-in gene targeting
technique (Sabblah et al., 2018). It is critical to remember that because a mouse
has a disease linked mutation, it does not mean that it would be a relevant model
to study that disease. A mouse model has to recapitulate the clinical
manifestations of the disease to be considered as a relevant model for studying
that disease. Therefore, a key question for the H304R mouse model was if the
H304R mice would develop and display the symptoms associated with CMT2O.
To answer this question, we performed extensive studies to investigate and
characterize the behavioral phenotype of the H304R mouse model. Several
phenotypic assessments and motor-skills tests were performed at multiple time
points to investigate if the H304R mouse model recapitulated the corresponding
phenotype associated with CMT2O. First, we started with breeding and growing
the heterozygous H304R/+ colony for preliminary behavioral assessments. The
initial assessments such as tail suspension reflex, grip strength, and rotarod test
were performed with the heterozygous H304R/+ male and female mice and the
data was compared with the wildtype mice. The preliminary findings between the
heterozygous H304R/+ and wildtype mice were published first (Sabblah et al.,
2018).
After seeing a promising phenotype with the heterozygous H304R/+ mice, we
decided to start another behavioral skills study with the homozygous H304R/R
mice. The homozygous H304R/R mice were then bred and grown into a colony
of mice. We compared the tail suspension reflex, grip strength, and rotarod data
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between the homozygous H304R/R mice and the wildtype control mice at
multiple ages (manuscript in submission).

3.3

Results

3.3.1 H304R mice had normal life span
The founder H304R knock-in mice were bred to yield both male and female
heterozygous H304R/+ mice. The heterozygous H304R/+ pups had a normal
birth and normal lifespan of 2 years (Sabblah et al., 2018). The heterozygous
H304R/+ mice did not appear to have any significant bodyweight differences and
were able to move around the cage just like their littermate wildtype control
animals.
The homozygous H304R/R pups were able to survive after birth unlike the other
dynein heavy chain homozygous mutant pups (Loa/Loa, Cra/Cra, Swl/Swl) and
had a normal lifespan (Chen et al., 2007; Hafezparast et al., 2003). The
homozygous H304R/R mice appeared to have gait defects such as a high
steppage gait in hind limbs (figure 3-2). Also, they were not as inclined to move in
the cage as compared to their littermate wildtype control and heterozygous
H304R/+ mice. They did not have any significant bodyweight differences
compared to their littermates.
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Figure 3-2 Gait phenotype of H304R mouse model
Homozygous H304R/R mice showed gait defects such as high steppage gait in hind
limbs (black arrow).

3.3.2 H304R mice showed atypical tail suspension phenotype
Tail suspension tests were performed to assess the phenotype of H304R mouse
model. Mice tend to splay their hind limbs away from their body when lifted by the
tails as their typical tail suspension reflex. However, in some cases, mice would
clench their hind limbs together and hold them close to their body as part of their
atypical tail suspension phenotype (Figure 3-3).
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Figure 3-3 Tail suspension phenotype of H304R mouse model
Typical tails suspension reflex consists of splaying of hind limbs away from the body,
whereas, atypical tail suspension involves clenching of hind limbs together closer to the
body.

The tail suspension reflex test was performed on the H304R colony at multiple
ages and the mouse’s phenotype was scored as typical or atypical reflex. The tail
suspension reflex was then statistically compared between the 3 genotypes
using the Chi-square test (p<0.05). We observed that about 20-30% of male and
female heterozygous H304R/+ mice started to display the atypical tail suspension
phenotype at later ages (9 and 12 months) as compared to the wildtype control
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mice (Figure 3-4). A majority (60-80%) of male and female homozygous
H304R/R mice significantly displayed the atypical tail suspension reflex
compared to the wildtype control and heterozygous H304R/+ mice right from an
early age. The tail suspension data is summarized in Table 3-1.

#

#

#

#

#

*

*

#

#

*

#

*

Figure 3-4 Atypical tail suspension response of H304R mouse model
Male and female heterozygous H304R/+ mice (gray bars) showed atypical tail
suspension reflex at later time points as compared to the wildtype mice (black bars)
(Chi-square test p<0.05). Whereas, both male and female homozygous H304R/R mice
(white bars) showed atypical tail suspension reflex at all the time points (Chi-square test
p<0.05). Note- * is the statistical significance as compared to the wildtype only and # is
the statistical significance as compared to the wildtype and H304R/+.
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Female mice

Male mice

Tail reflex

Table 3-1 Tail suspension reflex of H304R mice
Time
point

Percentage of mice showing
atypical tail suspension
reflex

Number of animals (n)

p-value
(Chi-square
test)

Wild-type

H304R/+

H304R/R

Wildtype

H304R/+

H304R/R

3
months

7.5%

2.0%

61.7%

34

25

26

0.0745 <0.0001

6
months

5.8%

11.2%

76.6%

46

34

20

0.0642 <0.0001

9
months

9.6%

21.6%

74.7%

29

27

20

0.0120 <0.0001

12
months

12.2%

27.3%

79.6%

40

42

18

0.0002 <0.0001

3
months

10.0%

15.4%

66.3%

9

8

27

0.5434 <0.0001

6
months

8.0%

12.5%

62.6%

35

21

20

0.2771 <0.0001

9
months

11.3%

18.6%

70.9%

54

37

19

0.0314 <0.0001

12
months

11.3%

18.5%

70.7%

56

44

19

0.0350 <0.0001
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Wildtype vs
H304R/+

Wildtype vs
H304R/R

3.3.3 Heterozygous H304R/+ mice show mild defects in their motor phenotype
Initial behavioral assessments were done with the male and female heterozygous
H304R/+ mice and the data was statistically compared with age and gender
matched wildtype control mice. The behavioral test results are as follows:
Heterozygous H304R/+ mice show reductions in grip strength
Standard grip strength assay was performed to assess the muscular strength in
all limbs and front limbs of heterozygous H304R/+ mice. The male heterozygous
H304R/+ mice showed a statistically significant reduction of about 10% in all
limbs grip strength at all ages as compared to the wildtype control mice
(Student’s t-test, p<0.05) (Figure 3-5). Female heterozygous H304R/+ mice
showed a statistically significant reduction of about 5% in all limbs grip strength
at only 6 and 9 month ages as compared to the wildtype control animals
(Student’s t-test, p<0.05).
Male heterozygous H304R/+ mice showed a statistically significant reduction of
about 7% in its front grip strength at later ages of 9 and 12 months as compared
to the wildtype mice (Student’s t-test, p<0.05). The female heterozygous
H304R/+ mice did not have any reductions in their front grip strength as
compared to the wildtype mice at any age. The grip strength data for male
H304R/+ and female H304R/+ mice are summarized in table 3-2 and table 3-3
respectively.
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Figure 3-5 Grip strength phenotype of heterozygous H304R/+ mice
Both male and female heterozygous H304R/+ mice showed significant reductions in all
limbs grip strength as compared to the wildtype mice (A & B). Only male heterozygous
H304R/+ mice showed significant reductions in front limbs grip strength at later time
points (C). The female heterozygous H304R/+ mice did not show any reductions in front
grip strength as compared to the wildtype control mice (D). Note- * Student’s t-test,
p<0.05.
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Table 3-2 Grip strength in H304R/+ male mice
Test
(male
mice)

All
limbs

Front
limbs

Time
point

Mean ± std. dev (grams)

Number of
animals (n)

p-value
(Student’s
t-test)

Wild-type

H304R/+

Wildtype

H304R/+

Wild-type
vs
H304R/+

3
months

212.5 ± 23.2

190.4 ± 26.8

50

43

0.0001

6
months

225.1 ± 30.8

201.0 ± 29.9

62

58

0.0001

9
months

230.6 ± 37.9

206.8 ± 33.4

41

42

0.0033

12
months

244.5 ± 32.1

225.3 ± 33.5

40

42

0.0096

3
months

99.2 ± 12.9

95.6 ± 17.4

50

43

0.2654

6
months

88.8 ± 14.3

83.8 ± 15.0

62

58

0.0667

9
months

89.8 ± 12.9

82.1 ± 11.1

41

42

0.0045

12
months

92.0 ± 11.9

86.1 ± 13.4

40

42

0.0362
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Table 3-3 Grip strength in H304R/+ female mice
Test
(female
mice)

All
limbs

Front
limbs

Time
point

Mean ± std. dev (grams)

Number of
animals (n)

p-value
(Student’s
t-test)

Wild-type

H304R/+

Wildtype

H304R/+

Wild-type
vs
H304R/+

3
months

175.5 ± 24.0

171.9 ± 22.0

51

35

0.4820

6
months

192.9 ± 15.9

185.7 ± 16.9

56

41

0.0324

9
months

209.8 ± 18.8

199.8 ± 16.5

55

41

0.0068

12
months

222.2 ± 22.2

216.4 ± 20.0

54

41

0.1843

3
months

91.0 ± 12.5

89.1 ± 12.2

51

35

0.4801

6
months

81.5 ± 9.8

81.8 ± 11.0

56

41

0.8959

9
months

81.3 ± 11.8

79.8 ± 11.1

55

41

0.5148

12
months

85.9 ± 13.4

85.4 ± 13.1

54

41

0.8681
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Heterozygous H304R/+ mice show deficits in the rotarod performance
Rotarod test was performed to assess the motor coordination phenotype of
H304R/+ mice. Mice were placed inside the rotarod equipment and their falling
off from the rotarod before the completion of the rotarod cycle was measured as
latency to fall (in seconds). The male heterozygous H304R/+ mice were falling
from the moving rotarod quicker than the wildtype mice (Table 3-5). They showed
significant reductions in their latency to fall (by about 25%) as compared to the
wildtype control animals at 3, 6 and 9 months of age (Student’s t-test, p value
<0.05) (Figure 3-6). Female heterozygous H304R/+ mice also showed a similar
trend (Table 3-5), but had a significant reduction of 20% in their latency to fall
only at an early age of 3 months as compared to the wildtype mice (Student’s ttest, p value <0.05).

Figure 3-6 Rotarod performance test of the H304R/+ mice
Male and female heterozygous H304R/+ mice showed significant defects in their rotarod
performance as compared to the wildtype at some time points (*Student’s t-test, p<0.05).
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Table 3-4 Rotarod performance in H304R/+ male mice
Test
(male
mice)

Rotarod

Time point

Mean ± std. dev
(seconds)

Number of
animals (n)

p-value
(Student’s
t-test)

Wild-type

H304R/+

Wildtype

H304R/+

Wild-type
vs
H304R/+

3 months

78.8 ± 40.9

55.2 ± 30.4

51

43

0.0019

6 months

95.5 ± 49.1

73.0 ± 42.4

48

41

0.0223

9 months

101.9 ± 52.9

74.6 ± 44.8

28

33

0.0359

12 months

100.7 ± 48.6

82.4 ± 45.7

20

25

0.2035

Table 3-5 Rotarod performance in H304R/+ female mice
Test
(female
mice)

Rotarod

Time point

Mean ± std. dev
(seconds)

Number of
animals (n)

p-value
(Student’s
t-test)

Wild-type

H304R/+

Wildtype

H304R/+

Wild-type
vs
H304R/+

3 months

103.6 ± 47.6

82.7 ± 34.3

51

35

0.0205

6 months

113.7 ± 54.9 104.9 ± 45.2

51

35

0.4210

9 months

106.8 ± 61.4 105.9 ± 54.0

51

35

0.9386

12 months

98.8 ± 62.6

50

35

0.3711

87.7 ± 51.3
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3.3.4 Homozygous H304R/+ mice show severe defects in their motor phenotype
After seeing the altered phenotype of motor skills in the heterozygous H304R/+
mice, we decided to perform behavioral assessments of the male and female
homozygous H304R/R mice. The data was statistically compared with age and
gender matched with the wildtype control mice. The behavioral test results are as
follows:

Homozygous H304R/R mice show reductions in grip strength
Standard grip strength assay was performed to assess the muscular strength in
all limbs and front limbs of heterozygous H304R/R mice. Male homozygous
H304R/R mice showed statistically significant reductions of about 30% in all
limbs grip strength as compared to the wildtype animals at all ages (Student’s ttest, p value <0.05) (Figure 3-7). Female homozygous H304R/R mice also
showed statistically significant reductions of about 20% in all limbs grip strength
as compared to the wildtype animals at all ages tested (Student’s t-test, p value
<0.05). Both male and female homozygous H304R/R mice did not show any
reductions in their front grip strength as compared to the wildtype mice at all
ages. Grip strength data for male homozygous H304R/R (Table 3-6) and female
homozygous H304R/R (Table 3-7) mice are summarized in the table below.
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Figure 3-7 Grip strength phenotype of heterozygous H304R/R mice
Both male and female homozygous H304R/R mice showed significant reductions in all
limbs grip strength (A & B) as compared to the wildtype controls. No grip strength
reductions were observed in the front limbs of both male and female homozygous
H304R/R mice (C&D). Note- * Student’s t-test, p value <0.05.
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Table 3-6 Grip strength in H304R/R male mice
Test
(male
mice)

All
limbs

Front
limbs

Time
point

Mean ± std. dev (grams)

Number of
animals (n)

p-value
(Student’s
t-test)

Wild-type

H304R/R

Wildtype

H304R/R

Wild-type
vs
H304R/R

3
months

212.5 ± 23.2

162.0 ± 46.3

50

26

<0.0001

6
months

225.1 ± 30.8

162.9 ± 31.4

62

20

<0.0001

9
months

230.6 ± 37.9

162.2 ± 38.6

41

20

<0.0001

12
months

244.5 ± 32.1

167.0 ± 31.3

40

18

<0.0001

3
months

99.2 ± 12.9

96.0 ± 23.6

50

26

0.9995

6
months

88.8 ± 14.3

84.6 ± 21.7

62

20

0.9970

9
months

89.8 ± 12.9

85.8 ± 18.8

41

20

0.9987

12
months

92.0 ± 11.9

84.1 ± 20.2

40

18

0.7910

77

Table 3-7 Grip strength in H304R/R female mice
Test
(female
mice)

All
limbs

Front
limbs

Time
point

Mean ± std. dev (grams)

Number of
animals (n)

p-value
(Student’s
t-test)

Wild-type

H304R/R

Wildtype

H304R/R

Wild-type
vs
H304R/R

3
months

175.5 ± 24.0

154.5 ± 23.0

51

27

0.0004

6
months

192.9 ± 15.9

164.9 ± 28.5

56

20

0.0004

9
months

209.8 ± 18.8

161.0 ± 29.5

55

19

<0.0001

12
months

222.2 ± 22.2

173.2 ± 39.2

54

19

<0.0001

3
months

91.0 ± 12.5

91.5 ± 15.5

51

27

>0.9999

6
months

81.5 ± 9.8

81.7 ± 17.0

56

20

>0.9999

9
months

81.3 ± 11.8

81.6 ± 17.9

55

19

>0.9999

12
months

85.9 ± 13.4

86.5 ± 21.1

54

19

>0.9999
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Homozygous H304R/R mice show deficits in the rotarod performance
Homozygous H304R/R mice were unable to keep up with the rotating rotarod
and were falling off the rod a lot quicker than the wildtype mice. Male
homozygous H304R/R mice showed statistically significant reductions in their
latency to fall as compared to the wildtype at all ages (Student’s t-test, p value
<0.05) (Figure 3-8). Similarly, female homozygous H304R/R mice also showed
statistically significant reductions in their rotarod performance as compared to the
wildtype mice at all ages tested (Student’s t-test, p value<0.05). Both male (Table
3-8) and female (Table 3-9) homozygous H304R/R mice showed about 65%
reduction in their latency to fall as compared to the wildtype mice.

Figure 3-8 Rotarod performance test of the H304R/R mice
Both male and female homozygous H304R/R mice showed significant defects in their
rotarod performance as compared to the wildtype at all ages (* - Student’s t-test, p value
<0.05).
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Table 3-8 Rotarod performance in H304R/R male mice
Test
(male
mice)

Rotarod

Time point

Mean ± std. dev
(seconds)

Number of
animals (n)

p-value
(Student’s
t-test)

Wild-type

H304R/R

Wildtype

H304R/R

Wild-type
vs
H304R/R

3 months

78.8 ± 40.9

25.0 ± 9.6

51

26

<0.0001

6 months

95.5 ± 49.1

22.4 ± 9.7

48

20

<0.0001

9 months

101.9 ± 52.9

17.8 ± 9.6

28

20

<0.0001

12 months

100.7 ± 48.6

18.8 ± 9.7

20

18

<0.0001

Table 3-9 Rotarod performance in H304R/R female mice
Test
(female
mice)

Rotarod

Time point

Mean ± std. dev (seconds)

Number of
animals (n)

p-value
(Student’s
t-test)

Wild-type

H304R/R

Wildtype

H304R/
R

Wild-type
vs
H304R/R

3 months

103.6 ± 47.6

28.1 ± 9.1

51

27

<0.0001

6 months

113.7 ± 54.9

30.8 ± 18.7

51

20

<0.0001

9 months

106.8 ± 61.4

23.9 ± 12.0

51

19

<0.0001

12 months

98.8 ± 62.6

23.2 ± 9.8

50

19

<0.0001
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3.4

Conclusions

We generated a novel H304R mouse model for Charcot-Marie-Tooth type 2O
(CMT2O) with a disease mutation in its dynein heavy chain. We performed
several phenotypic and behavioral assessments on male and female
heterozygous H304R/+ and homozygous H304R/R mice. The heterozygous
H304R/+ had a normal lifespan and survived until 2 years (end point of the
study). Similarly, the homozygous H304R/R mice had a normal lifespan unlike
the other dynein heavy chain mutant mice (Loa/Loa, Cra/Cra, and Swl/Swl) that
were embryonic or post-natal lethal (Chen et al. (2007); (Hrabe de Angelis et al.,
2000).
Male and female heterozygous H304R/+ mice showed an atypical tail suspension
reflex of hind limb clenching at later ages (9 and 12 months). The atypical tail
suspension phenotype could be indicative of motor dysfunction in lower
extremities (or hind limbs) of the mice. Male and female heterozygous H304R/+
mice showed significant reductions of 5-10% in their hind limbs grip strength.
Only male heterozygous H304R/+ mice showed significant reductions in the front
limbs grip strength at later ages (9 and 12 months). Additionally, male
heterozygous H304R/+ mice also showed significant ~25% reduction in the
rotarod performance almost at all the time points. Female heterozygous H304R/+
mice showed a significant ~20% reduction in the rotarod performance test at an
early age only (3 months).
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Male and female homozygous H304R/R mice appeared to have defects in their
gaits and were inclined to move less inside the cage as compared to their
littermates. The majority of homozygous H304R/R significantly showed atypical
tail suspension reflex right from an early age 3 months to all the way up to 12
months. Male and female homozygous H304R/R mice also showed significant
20-30% reductions in all limbs grip strength as compared to the wildtype mice,
but not in front limbs grip strength. Both male and female homozygous H304R/R
mice also performed poorly on the rotarod performance test with ~65% reduction
in latency to fall because they were unable to stay longer on the moving rod than
the wildtype control mice.

So far, our initial investigation and characterization of the novel H304R mice with
CMT2O mutation in DHC offered the following insights:


The H304R mouse model is a novel mouse model with a mutation in the
dynein heavy chain that is known to cause neuropathies in humans
(CMT2O and SMA-LED) (Tsurusaki et al. (2012); (Weedon et al., 2011).



The H304R mouse model was able to recapitulate and express the
symptoms of human neuropathies (CMT2O and SMA-LED) such as
muscle weaknesses, and motor coordination defects.



The heterozygous H304R/+ mutation expressed and recapitulated the
heterogeneity of motor phenotype in mice, similar to the heterogeneity of
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clinical symptoms seen in humans with the autosomal dominant CMT2O
mutation.


Quantitatively, the heterozygous H304R/+ mice displayed a milder
reduction in its motor skills phenotype, whereas, the homozygous
H304R/R mice displayed a severe reduction in its motor skills phenotype.



The male heterozygous H304R/+ mice appeared to be affected more
significantly by the mutant dynein function than the female heterozygous
H304R/+ mice.



The male heterozygous H304R/+ mice had a variable onset of the motor
phenotype, sometimes at an early age (reductions in all limbs grip strength
and rotarod tests) and sometimes at a later age (atypical tail suspension
and reduced front limbs grip strength).



Both male and female homozygous H304R/R mice appeared to be
affected equally by the mutant dynein function.



The homozygous H304R/R mice consistently had an early onset of motor
phenotype that was severely deficient right from the start. In addition, the
homozygous H304R/R mutation phenotype was also static and nonprogressive in nature, i.e. it was not worsening drastically as the mice
aged.



A dynein molecule contains a dimer of two DHC monomeric peptides
linked together. A unique advantage of the homozygous H304R/R
mutation is that the homozygous mice will have a uniform composition of
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dynein molecules with DHC dimers containing both mutant monomers. In
contrast, the heterozygous H304R/+ mutation leads to a mixed pool of
dynein in heterozygous mice, i.e. a quarter population of DHC dimers will
have both wildtype monomers, a quarter of DHC with both mutant
monomers, and half of the DHC dimers with one wildtype and one mutant
monomer.

In conclusion, the H304R mouse model appears to serve as a useful tool to
understand the role of dynein in neurodegenerative diseases. Future biochemical
studies with H304R mice can unveil the molecular mechanism of the mutant
dynein function in neurons.
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CHAPTER 4: SENSORY PHENOTYPE CHARACTERIZATIONS OF
H304R MICE
4.1

Introduction

Many CMT patients show the symptoms of sensory neuropathy along with motor
neuropathy. Common sensory deficits reported in CMT patients include loss of
sensation

in

distal

limbs,

paresthesia

(tingling

sensation),

reduced

proprioception, and some patients also displayed reduction in their fine touch and
vibration sense (Weedon et al., 2011). Due to loss of sensation in their lower
limbs, some patients lose sensitivity to pain due to any foot wounding.
Consequently, that further leads to complications of foot ulcerations and usually a
follow up surgery is needed to remove the damaged foot/toes. It is worth noting
that previously published dynein heavy chain mutant mice (Loa, Cra and Swl)
reported sensory deficits in their phenotype (Chen et al., 2007; Dupuis et al.,
2009) as outlined below.
4.1.1 Sensory deficits in previously published mutant dynein mice models
The sciatic nerve is the largest nerve in the body, and it innervates the lower limb
muscles of mice. The outer layer of dense irregular connective tissue around a
sciatic nerve is called epineurium (Figure 4-1). The sciatic nerve is made up of
fascicles i.e. the several bundles of neuronal axons that are enclosed together.
The outer layer of a fascicle is lined with perineural glial cells and is called the
perineurium. The extracellular matrix space between neuronal axons inside a
fascicle is called the endoneurium.
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Figure 4-1 Sciatic nerve cross section
The sciatic nerve is covered with a layer of connective tissue called epineurium and
contains several nerve bundles called fascicles. The fascicles are lined with glial cells
that make up a layer called perineurium. The extracellular space around the bundles of
axons inside the fascicles is called endoneurium.

Deficits in the sciatic nerve anatomy have been linked to sensory dysfunction in a
previously reported dynein heavy chain mutant mouse (Chen et al., 2007). Both
heterozygote Loa/+ and heterozygote Swl/+ mice reportedly had thinner sciatic
nerves as compared to wildtype animals. Both ventral root and dorsal root
contribute their spinal nerves (neuronal axons) to make up the sciatic nerve. It
was observed and determined that the dorsal root size was smaller in both
heterozygote Loa/+ and Swl/+ mice as compared to wildtype controls, whereas
the ventral root size was unchanged. The Cra/+ mice also showed thinner dorsal
roots and loss of large caliber axons (Dupuis et al., 2009)
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A dorsal root ganglion is a cluster of neuronal cell bodies or somas of pseudounipolar sensory neurons. The dorsal root ganglia (DRG) receive input signals
from sensory neurons innervating target tissue such skin, muscles, and organs.
Input nerve signals travel along the sensory neuron axons in ‘afferent direction’
i.e. from target tissue to dorsal root ganglia and further passed onto the spinal
column for signal processing. Additionally, the dorsal root ganglion is composed
of different neuronal subpopulation involved in sensory stimulus reception. For
example, nociceptive neuronal subpopulation inside a dorsal root ganglion is
responsible for sensing pain stimulus from the target tissue such as skin. Another
example inside a dorsal root ganglion is the proprioceptive neuronal
subpopulation that is involved in sensing the muscle stretch and orientation.
In the study mentioned above, the DRG in heterozygote Loa/+ and heterozygote
Swl/+ mice were also examined, and they revealed interesting insights into the
DRG neuronal subpopulation composition (Chen et al., 2007). It was determined
that the total number of neurons were significantly reduced in dorsal root ganglia
from lumbar (L4) spinal region of heterozygote Loa/+ and heterozygote Swl/+
mice. Specifically, it was determined that proprioceptive neuronal subpopulations
were reduced by 69% in the dorsal root ganglia (L4) of newly born heterozygote
Swl/+ animals. Proprioceptive neuronal subpopulation count was not studied in
heterozygote Loa/+ mice. In conclusion, the sensory studies on heterozygote
Loa/+ and Swl/+ mice laid out the basis for investigating the sensory phenotype
of the H304R mouse model.
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4.2

Rationale

We focused on the motor behavior skills characterization of the novel H304R
mouse in our initial studies and observed deficits in the tail suspension, grip
strength and the motor coordination phenotype of the mice. Here I start
investigating the sensory phenotypes of H304R mice to understand and compare
those to the sensory phenotypes of previously published dynein heavy chain
mutant mice (Loa/+ and Swl/+).
First, I started with assessing the sensory behavior phenotype by exposing
wildtype, heterozygous H304R/+, and homozygous H304R/R mice (both male
and female) to the tail flick sensitivity test and recorded their response to pain
stimulus at early (1 month and 3 months) and a later (12 months) time point.
Based on the tail flick data, I selected the male H304R mice cohort at 3 and 12
months’ time points for further sensory tissue investigation. I examined the gross
anatomy of sciatic nerve in the wildtype, heterozygous H304R/+, and
homozygous H304R/R male mice at 3 and 12 months of age and compared its
thickness in all three genotypes. I dived deeper into quantitative analysis of
sciatic nerve thickness by comparing the total fascicular area in the sciatic nerve
from the male H304R mice of all three genotypes. Because the dorsal root
ganglia (DRG) contribute its axons to the sciatic nerve, I refined and optimized
conditions to study the DRG composition to further understand the sciatic nerve
phenotype of the H304R mouse model.
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4.3

Results

4.3.1 Altered latency to respond to pain stimulus in H304R mice
The tail flick test was used to measure the sensitivity of H304R mice to thermal
pain stimulus. A test mouse was restrained safely in a restrainer and its tail was
briefly exposed to a thermal light beam as a source of pain stimulus at a
moderate intensity setting (50 out of 99 on the setting scale). The tail flick meter
recorded the time (in seconds) that a mouse would take to remove its tail out of
the thermal light beam path (pain stimulus). Both male and female cohorts of
H304R mice were tested on the tail flick test at multiple time points and their data
was compared respectively between the three genotypes.
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Figure 4-2 Tail flick pain sensitivity test of H304R male mice
Male homozygous H304R/R mice displayed a significantly quicker response to the pain
stimulus at 3 months and 12 months of age as compared to their respective wildtype
control male mice (One-way ANOVA, p<0.05). Only 3 month female homozygous
H304R/R mice displayed a significant quicker response to the pain stimulus as
compared to the wildtype control female mice (One-way ANOVA, p<0.05). 12 month old
female homozygous H304R/R data is not presented due to the unavailability of mice.
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Interestingly, both heterozygous H304R/+ and homozygous H304R/R male mice
took less time to respond to the pain stimulus than the wildtype control mice
(Figure 4-2) at multiple time points. However, the quick response time was
statistically significant only in the homozygous H304R/R male mice at 3 months
and 12 months of age (One-way ANOVA, p<0.05) as compared to the wildtype
mice. There was no significant difference between the pain response time of
heterozygous H304R/+ and homozygous H304R/R male mice at any time points
tested (Table 4-1).
Female heterozygous H304R/+ and homozygous H304R/R mice did not show
any significant differences in their tail flick response times as compared to the
wildtype control female mice at 1 month of age. However, at 3 months of age,
both heterozygous H304R/+ and homozygous H304R/R female mice took lesser
time to respond to the pain stimulus. But only homozygous H304R/R female mice
had a statistically significantly quicker response time as compared to the wildtype
control mice (One-way ANOVA, p<0.05). The tail flick data for 12 month old
female homozygous H304R/R mice is not presented due to a lack of the mouse
availability. There was no significant difference between the pain response time
of heterozygous H304R/+ and homozygous H304R/R female mice at all time
points.
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Table 4-1 Tail flick data
Average time of response (sec), number of animals (n), and the one-way ANOVA test p-values (with Tukey’s multiple
comparison test) for the wild-type, heterozygous (H304R/+) and homozygous (H304R/R) mice

female mice

Male mice

Tail
flick
test

Time
point
(age)

Average time of response
to the pain stimulus
(seconds)

Number of animals (n)

p-value (Tukey’s multiple
comparison)

Wildtype

H304R/+

H304R/R

Wildtype

H304R/+

H304R/R

Wildtype vs
H304R/+

Wild-type
vs
H304R/R

H304R/+
vs
H304R/R

1 month

8.13

7.28

4.46

3

13

2

0.9051

0.4203

0.4743

3 months

8.64

6.40

5.21

7

18

6

0.0843

0.0284

0.5117

12 months

8.43

7.17

4.48

4

6

5

0.6272

0.0370

0.1227

1 month

7.60

7.77

7.86

5

9

4

0.9876

0.9796

0.9968

3 months

8.43

7.04

4.59

9

12

4

0.3108

0.0163

0.1335

12 months

10.43

7.83

N/A

4

4

N/A

N/A

N/A

N/A
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4.3.2 Sciatic nerve appeared thinner in H304R mice
The sciatic nerve is the largest nerve in the body and it innervates the lower
limbs of mice. The sciatic nerve arises from spinal nerves L3, L4, and L5 from the
lumbar spinal column in mice. Dissections were performed on euthanized
wildtype, heterozygous H304R/+, and homozygous H304R/R male mice to
expose & collect both left and right sciatic nerves. Then, the tissue was frozen,
sectioned and stained with immunohistochemistry-based methods to compare
the sciatic nerve thickness between the three genotypes.
Sciatic nerve dissections were done on two litters each of 3 months and 12
month old wildtype, heterozygous H304R/+, and homozygous H304R/R male
mice. Visually, it appeared that both the left and right sciatic nerves were thinner
in the male homozygous H304R/R mice as compared to the wildtype and
heterozygous H304R/+ littermate control (Figure 4-3). Heterozygous H304R/+
mice appeared to have sciatic nerves of similar or slightly reduced thickness as
compared to the wildtype littermate control animals. These visual observations of
sciatic nerve were then further validated by quantitatively measuring the nerve
thickness and axonal counts using immunohistochemistry-based staining
methods as described next.
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Wild-type

H304R/+

H304R/R

Figure 4-3 Comparison of sciatic nerve thickness of H304R male mice
The sciatic nerve appeared to be thinner in 3-month homozygous H304R/R male mice
as compared to the wildtype and heterozygous H304R/+ littermates.

4.3.3 Reduced total sciatic nerve fascicular area in H304R mice
After seeing apparent differences in sciatic nerve thickness of H304R mice, I
wanted to quantify this observed difference by measuring the total fascicular
area. The sciatic nerve is made up of fascicles or bundle of neuronal axons
enclosed within the perineurium layer. Fascicular area was calculated by
measuring the area enclosed inside perineurium layer of fascicles that was
stained by a perineural marker - glucose transporter GLUT-1 antibody (details in
Chapter 2: Materials and methods). Total area of all the fascicles were added
together and compared between the 3-month (Figure 4-4) and 12-month (Figure
4-5) old wildtype, heterozygous H304R/+, and homozygous H304R/R male mice
respectively.
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Wild-type

H304R/+

H304R/R

Litter #1

Litter #2

Figure 4-4 Sciatic nerve cross sections of 3-month H304R male mice
Sciatic nerve cross sections were stained with perineural glial maker – GLUT 1 (shown here in red) to label individual
fascicles. Total fascicular area was calculated for all fascicles and compared between the genotypes. Homozygous H304R/R
mice showed a significant reduction in the total fascicular area as compared to wildtype littermate control. No significance
differences were observed between heterozygous H304R/+ and wildtype mice.
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Wild-type

H304R/+

H304R/R

Litter #1

Litter #2

Figure 4-5 Sciatic nerve cross sections of 12-month H304R male mice
Sciatic nerve cross sections were stained with perineural glial maker – GLUT 1 (shown here in red) to label individual
fascicles. Total fascicular area was calculated for all fascicles and compared between the genotypes. Homozygous H304R/R
mice showed a significant reduction in the total fascicular area as compared to wildtype littermate control. No significance
differences were observed between heterozygous H304/R+ and wildtype mice.
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By visual observation, the sciatic nerve appeared thinner in homozygous
H304R/R male mice as compared to the wildtype littermate control animal at both
3 months and 12 months of age. This result was quantitatively confirmed by
observing a significant overall reduction of about 40% in total fascicular area of
homozygous H304R/R mice as compared to the wildtype control (One-way
ANOVA, Tukey’s multiple comparisons test, p<0.05) at 3 months and 12 months
age (Figure 4-6). Heterozygous H304R/+ mice also showed about 16% reduction
in the total fascicular area as compared to the wildtype littermate control animal
at 3 months and 12 months age, but this difference was not statistically
significant. Total fascicular area differences between homozygous H304R/R and
heterozygous H304R/+ male mice were not significant (Table 4-2).

Sciatic nerve thickness
Total fascicular area (mm2)

0.2
0.15

*

*

0.1

Wildtype
H304R/+
H304R/R

0.05

0
3 months

12 months

Figure 4-6 Total fascicular area of sciatic nerve in H304R male mice
Homozygous H304R/R male mice had a statistically significant reduction of ~40% in its
total fascicular area as compared to the wildtype control mice (1-way ANOVA, Tukey’s
multiple comparisons test, p<0.05).
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Table 4-2 Total fascicular area in the sciatic nerve of H304R male mice
Total

Wildtype

Heterozygous

Homozygous

H304R/+

H304R/R

0.20 mm2

0.16 mm2

0.12 mm2

0.16 mm2

0.14 mm2

0.09 mm2

0.18 mm2

0.15 mm2

0.11 mm2

Wildtype

Heterozygous

Homozygous

H304R/+

H304R/R

0.19 mm2

0.20 mm2

0.12 mm2

0.17 mm2

0.10 mm2

0.10 mm2

0.18 mm2

0.15 mm2

0.11 mm2

fascicular area
3-month
littermate #
3-month
littermate #2
Average 3 month area

Total
fascicular area
12-month
littermate #1
12-month
littermate #2
Average 12 month area
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4.3.4 Axonal counts in the sciatic nerve cross section
After seeing a reduction in the total fascicular area of the sciatic nerve, it was
apparent that the axon numbers inside the fascicles were needed to be counted
to reveal any alterations that may have led to this reduction. Alterations in total
fascicular area could be a result of reduced number of the axons or a reduction in
the myelination that could ultimately lead to the thinner nerves of heterozygous
H304R/+ and homozygous H304R/R mice.
The largest βIII tubulin stained fascicle from each genotype of 3-month littermate
male mice was selected (Figure 4-7). The axons were counted and recorded in
two categories based on their appearances – single axons and bundled axons. A
small and uniform green dot was counted as a single axon, while the larger
shaped green dot was counted as a bundle of multiple axons inside the fascicle.
Then the percentage of bundled axon over total axons and the percentage of
single axons over total axons were calculated and compared separately for all
three genotypes (Table 4-3). The preliminary results revealed a reduction in the
number of axons in both the heterozygous H304R/+ and homozygous H304R/R
mice (Figure 4-8). However, the percentage distribution of the total axons into
bundled axons or single axons categories were similar in all three genotypes
(Figure 4-9).
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Wildtype

H304R/+

H304R/R

Figure 4-7 The largest fascicle inside the sciatic nerve of each genotype
The cross-sectional area of the largest fascicle inside each sciatic nerve was stained with the βIII tubulin antibody. Each
green dot was counted as a single axon and a bunch of green dots were counted as a bundle of multiple axons.
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Table 4-3 Axon counts inside the largest fascicle
3 months

Wildtype

H304R/+

H304R/R

Bundled axons

629

461

362

Single axons

579

397

282

Total axons

1208

858

644

% of bundled axons

52.07%

53.73%

56.21%

% of single axons

47.93%

46.27%

43.79%

Figure 4-8 Total count of axons inside a fascicle
The total number of axons was counted in the cross-sectional area of the largest fascicle
inside each sciatic nerve.
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Figure 4-9 The percentage distribution of bundled axons vs single axons
The distribution of the total axons in the categories – bundled axons and single axons
were similar in all three genotypes.
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4.3.5 Identifying subpopulations of neurons in the adult DRG
After observing a significant reduction in sciatic nerve thickness and axonal count
in H304R mice, I wanted to determine if there was a corresponding alteration in
the dorsal root ganglia (DRG) composition. The DRG contribute its neuronal
axons to make up the sciatic nerves. The DRG contain a mixed subpopulation of
neurons such as nociceptive neurons (to sense pain) and proprioceptive neurons
(to sense muscle stretch and orientation). DRGs collected from the lumbar (L4)
region of wildtype, heterozygous H304R/+, and homozygous H304R/R male mice
were sectioned serially every 10µm and stained with anti-βIII tubulin antibody to
label all the neuronal somas (Figure 4-10).
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Wildtype
H304R/+
H304R/R
Figure 4-10 Serial sections of dorsal root ganglia of H304R mice
The dorsal root ganglia from L4 lumbar region were serially sectioned. Best matched sections shown here in blue and orange
boxes were picked for further analysis between the wildtype, heterozygous H304R/+ and H304R/R male mice.
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Best matched sections of L4 dorsal root ganglia were picked from wildtype,
heterozygous H304R/+, and homozygous H304R/R male mice for further staining
with neuronal subpopulation specific makers (Figure 4-11). I successfully
optimized the working conditions to stain dorsal root ganglia sections with antiCGRP antibody to label nociceptive neurons and with anti-Parvalbumin (PV)
antibody to label the proprioceptive neurons (Figure 4-11). This optimized
methodology (Table 4-4) can be further used to stain and count the anti-PV
positive

neurons

(proprioceptors)

and

the

anti-CGRP

positive

identifying

DRG

neurons

(nociceptors).
Table 4-4 Optimized
subpopulations

conditions

for

Primary antibody

Working concentration

Mouse anti- βIII tubulin

1:200

Goat anti-CGRP

1:100

Rabbit anti- parvalbumin

1:100

Secondary antibody

Working concentration

Donkey anti- mouse 350

1:200

Donkey anti- goat 488

1:100

Donkey anti- rabbit 568

1:200
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neuronal

Notes
Primary antibody
dilutions are to be
prepared in the Block
buffer prepared with
Bovine Serum Albumin
(BSA).
Overnight incubation at
4°C.
Notes
Goat secondary
antibody dilutions are to
be prepared in the Block
buffer prepared with
Bovine Serum Albumin
(BSA).
3 hours incubation at
room temperature.

Counting subpopulation numbers of anti-PV positive neurons and anti-CGRP
positive neurons can be used to calculate and compare the percentage of each
subpopulation over total neurons present in the DRG of H304R mice. Preliminary
data for the wildtype DRG is presented in table 4-5. Out of all the βIII tubulin
stained neurons, ~ 36% of the neurons were anti-PV positive and ~59% of the
neurons were anti-CGRP positive in the same section of the wildtype DRG.

Table 4-5 Preliminary counts of wildtype DRG subpopulation
Subpopulation
Total cell bodies
anti-PV positive cell bodies
anti-CGRP positive cell bodies
% anti-PV positive cell bodies
% anti-CGRP positive cell bodies

Counts
39
14
23
35.90%
58.97%
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Figure 4-11 Neuronal subpopulations staining of dorsal root ganglia
The dorsal root ganglia section from wildtype mice was stained with anti-βIII tubulin to identify all sensory neurons. The
section was co-labelled with anti-parvalbumin and anti-CGRP primary antibodies to identify proprioceptive and nociceptive
neuronal subpopulations respectively.
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4.4

Conclusions

Charcot-Marie-Tooth patients exhibit sensory neuropathy symptoms in addition
to the motor neuropathy symptoms. In parallel, previously published dynein
heavy chain mutant Loa/+, Cra/+ and Swl/+ mice have also reported sensory
deficits (Chen et al., 2007; Dupuis et al., 2009). Based on the reports in human
CMT patients and previously published mutant dynein mice, I initiated the
sensory phenotype assessments of the H304R mouse model.
First, I started with characterizing the pain sensitivity response of H304R mice
with the tail flick test and found that both male and female homozygous H304R/R
mice had a statistically significant quicker response time to the pain stimulus than
the wildtype mice at 3 months of age. Male homozygous H304R/R mice also
showed a statistically significant quicker response time at 12 months of age as
compared to the wildtype mice. However, due to unavailability of female
homozygous H304R/R mice, no data was presented for comparison at 12
months. Heterozygous H304R/+ male mice also showed a quicker response to
tail flick test but didn’t have any significant differences as compared to the
wildtype control or homozygous H304R/R littermate mice at multiple time points.
It was previously reported that the heterozygote Loa/+ mice took a longer time to
respond to the tail flick test (unpublished data, (Banks and Fisher, 2008)). In
contrast, the H304R mutant mice took lesser time to respond on the tail flick test.
These contrasting observations indicate that the H304R mutation in the dynein
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heavy chain might be affecting nociceptive neurons differently than the Loa
mutation (F580Y) in the dynein heavy chain.
Next, a closer examination of sciatic nerve anatomy revealed that homozygous
H304R/R mice had thinner sciatic nerves as compared to both the wildtype and
heterozygous H304R/+ littermate mice. Quantitatively homozygous H304R/R
mice had an overall reduction of ~40% in total fascicular area of its sciatic nerve
as compared to the wildtype littermates at 3 months and 12 months of age.
Heterozygous H304R/+ mice displayed a slight 16% reduction in the total
fascicular area at 3 months and 12 months of age, but this difference was not
statistically significant as compared to the wildtype littermate control animals.
Reductions in the sciatic nerve thickness of H304R mice were similar to the
observations of thinner sciatic nerves in the Loa/+ and Swl/+ mice (unpublished
data, (Banks and Fisher, 2008)). Repetition of sciatic nerve experiments needs to
be performed on more number of animals to confirm this preliminary observation.
Observations of the sciatic nerve appearing thinner and reduction in the total
fascicular area in the heterozygous H304R/+ and homozygous H304R/R mice
opened many interesting follow up questions. That is why counting the number of
axons inside the largest fascicle was the next key step to determine the potential
reason behind the observed reduction in the total fascicular area. The preliminary
data from a littermate set revealed that there was a reduction in the number of
the axons in both the heterozygous H304R/+ (~29%) and homozygous H304R/R
(47%) mice as compared to the wildtype control. However, the percentage
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distribution of the bundled axons vs single axons was same in the fascicles from
all three genotypes. Reduced number of axons could be a potential reason
behind the thinner sciatic nerves inside the mutant H304R mice; however, further
investigations are necessary to establish this preliminary observation.
Because the sciatic nerve is a “mixed nerve”, it receives axons from both the
dorsal root (sensory neurons) and ventral root (motor neurons) of the spinal
column. The reduction in the diameter of sciatic nerve could be due to the loss of
axonal projections from the dorsal root and/or the ventral root. In order to answer
this question, I picked the sensory route or the dorsal root ganglia (DRG) to study
further.
As mentioned previously in this chapter, DRG has a mixed neuronal
subpopulation of sensory neurons that could be identified for quantitative
analysis. I successfully optimized the working conditions to label and identify the
neuronal subpopulation in the DRG of H304R mice. Future experiments using
these optimized conditions can be used to label all neurons with the βIII-tubulin
marker, proprioceptive neurons with the parvalbumin marker, and nociceptive
neurons with the calcitonin gene related protein (CGRP) marker. Next, these
labelled neuronal subpopulations can be quantitatively analyzed to calculate the
percentage of proprioceptive or nociceptive subpopulation over all the neurons
inside a DRG. Preliminary calculations with the wildtype DRG showed that ~36%
of all neuronal cell bodies were anti-parvalbumin positive cell bodies and nearly
~59% of all neurons were anti-CGRP positive cell bodies in the same stained
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section of the DRG. Further quantitative subpopulation comparisons may reveal
some key differences in the composition of DRG in the three genotypes of the
H304R mice.
Overall, my preliminary work to characterize the sensory phenotype of H304R
mice revealed some interesting differences in the pain sensitivity response and
sciatic nerve anatomy of mutant heterozygous H304R/+ and homozygous
H304R/R mice. The sciatic nerve anatomy of mutant heterozygous H304R/+ and
homozygous H304R/R mice was also comparable with previously published
dynein mice (Loa/+ & Swl/+) as outlined above. Further in-depth studies with a
greater number of animals will be required to establish the preliminary
observation of reduced sciatic nerve thickness in the H304R mice. Subsequent
studies exploring and comparing the DRG neuronal subpopulations between the
three genotypes would be needed to get a deeper explanation of the preliminary
observations in the sensory phenotype of H304R mice.
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CHAPTER 5: MOTILITY STUDIES OF H304R MICE
5.1

Introduction and rationale

Dynein is the key motor protein involved in the retrograde transport of cargoes
along the neuronal axon (Hirokawa et al., 1990). Direct role of dynein has been
established in the retrograde transport of neurotrophin mediated trk receptors
towards the neuronal soma for survival response (Heerssen et al., 2004; Yano et
al., 2001), fast axonal transport (Waterman-Storer et al., 1997), neurite growth
and organization (Ahmad et al., 1998), and neuronal migration (Tanaka et al.,
2004). Therefore, it is not surprising that the mutations in dynein have been
reported to show the impaired axonal transport in the DHC mutant Loa/+ mice
(Ori-McKenney et al., 2010) and in Swl/+ mice (Zhao et al., 2016).
Hence, we were also interested in investigating the intracellular motility
phenotype of H304R mouse model. Because previously studied DHC mutant
Loa/Loa mice showed defects in the development of its cortical and hippocampal
regions (Ori-McKenney and Vallee, 2011), we chose neurons from these areas
for our initial motility studies. We started with isolating cortical and hippocampal
neurons from H304R embryos (at E16.5) because embryonic neurons are easier
to grow in vitro than the adult mice neurons. Motility studies with established
dynein cargoes such as synaptophysin containing synaptic vesicles (Li et al.,
2000) and Rab7 positive vesicles (Johansson et al., 2007) were performed in
cortical and hippocampal embryonic neuronal cultures.
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5.2

Results

5.2.1 Synaptophysin-RFP positive vesicular motility in hippocampal neurons
Hippocampal neurons from H304R mice were isolated and plated on coverslips
for intracellular motility experiments. The neurons from the same genotype were
pooled together independent of the gender of the embryo. Hippocampal neurons
were then infected with BacMam synaptophysin-RFP and were imaged at the
ages DIV 10 and 14 (more details in the methods chapter section 2.5). Various
parameters such as the number of movements in the inward (towards the cell
body) and outward (away from the cell body) directions, run length or distance
(µm), and velocity (µm/sec) were recorded of the synaptophysin-RFP positive
vesicles that were moving. The data was then analyzed and statistically
compared between the three genotypes. The wildtype mice are referred as HH,
the heterozygous mice are referred as HR, and the homozygous mice are
referred as RR in this chapter.
At DIV 10, synaptophysin-RFP positive vesicles in homozygous H304R/R mice
showed an unusual distribution of movement patterns i.e. about 83% of vesicles
were moving in the inward direction as compared to about 45% of inward
direction bound vesicles in both the wildtype and heterozygous H304R/+ mice
(Table 5-1). Subsequently, about 17% of vesicles were outward direction bound
in the homozygous H304R/R mice as compared to about 55% outward direction
vesicles in both the wildtype and heterozygous H304R/+ mice.
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Table 5-1 Synaptophysin-RFP positive vesicles motility in hippocampal
neurons at DIV 10

Furthermore, both inward and outward bound synaptophysin-RFP positive
vesicles in heterozygous H304R/+ mice showed a slight (but insignificant)
increase in the distance (µm) covered as compared to the wildtype and
homozygous H304R/R mice (Figure 5-1). Both heterozygous H304R/+ and
homozygous H304R/R mice showed a slight reduction in the velocity (µm/sec) of
the inward and outward bound synaptophysin-RFP positive vesicles as
compared to the wildtype mice, but this reduction was not found to be statistically
significant (Figure 5-1).
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A

B

C

D

Figure 5-1 Synaptophysin-RFP positive vesicles motility in hippocampal
neurons at DIV 10
The graphs show the distance (µm) covered by the vesicles in the inward (A) and
outward (B) bound directions. The graphs show the velocity (µm/sec) of the vesicles in
the inward (C) and outward (D) bound directions. Wildtype (black bars), heterozygous
H304R/+ mice (gray bars), and homozygous H304R/R mice (blue bars).

At DIV 14, synaptophysin-RFP positive vesicles in homozygous H304R/R mice
showed an altered distribution of movement patterns. About 32% of
Synaptophysin-RFP positive vesicles were moving in inward direction as
compared to about 50-60% of inward bound vesicles in the wildtype and
heterozygous H304R/+ mice (Table 5-2).
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Subsequently, 68% of synaptophysin-RFP positive vesicles were moving in
outward direction as compared to about 40-50% of outward-bound vesicles in the
wildtype and heterozygous H304R/+ mice.
Table 5-2 Synaptophysin-RFP positive vesicles motility in hippocampal
neurons at DIV 14

Interestingly, synaptophysin-RFP positive vesicles in homozygous H304R/R mice
displayed a significant increase in the distance covered (µm) as compared to the
wildtype and heterozygous H304R/+ mice (One-way ANOVA, p<0.05) (Figure 52). Heterozygous H304R/+ mice showed slight but insignificant increase in its
vesicular distance coverage as compared to the wildtype mice. However, the
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synaptophysin-RFP positive vesicles in heterozygous H304R/+ mice showed a
significant decrease in its velocity (µm/sec) as compared to both wildtype and
homozygous H304R/R mice (One-way ANOVA, p<0.05) (Figure 5-2).
A

B

C

D

Figure 5-2 Synaptophysin-RFP positive vesicles motility in hippocampal
neurons at DIV 14
The graphs show the distance (µm) covered by the vesicles in the inward (A) and
outward (B) bound directions. The graphs show the velocity (µm/sec) of the vesicles in
the inward (C) and outward (D) bound directions. Wildtype (black bars), heterozygous
H304R/+ mice (gray bars), and homozygous H304R/R mice (blue bars). Note: * shows
statistical significance (1-way ANOVA, p<0.05).
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5.2.2 Synaptophysin-RFP positive vesicular motility in cortical neurons
Cortical neurons from H304R mice were isolated and plated on coverslips for
intracellular motility experiments. The neurons from the same genotype were
pooled together independent of the gender of the embryo. Cortical neurons were
then infected with BacMam synaptophysin-RFP and were imaged at the ages
DIV 10 and 14. Various parameters such as the number of movements in the
inward (towards the cell body) and outward (away from the cell body) directions,
run length or distance (µm), and velocity (µm/sec) were recorded of the
synaptophysin-RFP positive vesicles that were moving. The data was then
analyzed and statistically compared between the three genotypes.
At DIV 10, synaptophysin-RFP positive vesicles in both heterozygous H304R/+
and homozygous H304R/R mice showed an altered distribution of movement
patterns. About 63% of the vesicles in H304R mutant mice were moving in the
inward direction as compared to about 82% of inward direction bound vesicles in
the wildtype mice (Table 5-3). Subsequently, about 40% of vesicles were
outward direction bound in both heterozygous H304R/+ and homozygous
H304R/R mice as compared to only about 18% outward direction vesicles in the
wildtype mice.
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Table 5-3 Synaptophysin-RFP positive vesicles motility in cortical neurons
at DIV 10

Furthermore, both inward and outward bound synaptophysin-RFP positive
vesicles in heterozygous H304R/+ and homozygous H304R/R mice showed an
alteration in the distance (µm) covered as compared to the wildtype, but this
alteration was not significantly different statistically (Figure 5-3). Heterozygous
H304R/+ mice showed a slight (but insignificant) increase in the velocity (µm/sec)
of the inward and outward bound synaptophysin-RFP positive vesicles as
compared to the wildtype and homozygous H304R/R mice (Figure 5-3).
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B

C
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Figure 5-3 Synaptophysin-RFP positive vesicles motility in cortical neurons
at DIV 10
The graphs show the distance (µm) covered by the vesicles in the inward (A) and
outward (B) bound directions. The bottom graphs show the velocity (µm/sec) of the
vesicles in the inward (C) and outward (D) bound directions. Wildtype (black bars),
heterozygous H304R/+ mice (gray bars), and homozygous H304R/R mice (blue bars).

At DIV 14, synaptophysin-RFP positive vesicles showed a similar distribution of
movement patterns in all 3 genotypes. About 50-60% of the vesicles in H304R
mice was moving in the inward direction and about 40-50% of the vesicles were
outward direction bound in all three genotypes (Table 5-4).
119

Table 5-4 Synaptophysin-RFP positive vesicles motility in cortical neurons
at DIV 14

Both inward and outward bound synaptophysin-RFP positive vesicles had similar
distance (µm) covered in all 3 genotypes as well (Figure 5-4). Heterozygous
H304R/+ mice showed a peculiar pattern in the velocity (µm/sec) characteristic of
the inward and outward bound synaptophysin-RFP positive vesicles as
compared to the wildtype and homozygous H304R/R mice (Figure 5-4). Velocity
of synaptophysin-RFP positive vesicles was decreased in the inward bound
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direction and increased in the outward bound direction as compared to both the
wildtype and homozygous H304R/R mice, but this difference was not statistically
significant (Figure 5-4).
A

B

C

D

Figure 5-4 Synaptophysin-RFP positive vesicles motility in cortical neurons
at DIV 14
The graphs show the distance (µm) covered by the vesicles in the inward (A) and
outward (B) bound directions. The bottom graphs show the velocity (µm/sec) of the
vesicles in the inward (C) and outward (D) bound directions. Wildtype (black bars),
heterozygous H304R/+ mice (gray bars), and homozygous H304R/R mice (blue bars).
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5.2.3 Rab7-GFP positive vesicular motility in cortical neurons
Cortical neurons from H304R mice were isolated and plated on coverslips for
intracellular motility experiments. The neurons from the same genotype were
pooled together independent of the gender of the embryo. Cortical neurons were
nucleofected with Rab7-GFP and were imaged at the age DIV 10. Various
parameters such as the number of movements in the inward (towards the cell
body) and outward (away from the cell body) directions, run length or distance
(µm), and velocity (µm/sec) were recorded of the synaptophysin-RFP positive
vesicles that were moving. The data was then analyzed and statistically
compared between the three genotypes.
At DIV 10, Rab7-GFP positive vesicles in both heterozygous H304R/+ and
homozygous H304R/R mice showed a similar distribution of movement patterns
in both inward and outward directions as compared to the wildtype mice (Table 55). The Rab7-GFP positive vesicles in homozygous H304R/R mice showed an
increase in the distance (µm) covered by them in the inward direction, but this
difference was not significant compared to the wildtype and heterozygous
H304R/+ mice.
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Table 5-5 Rab7-GFP positive vesicles motility in cortical neurons at DIV 10
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Figure 5-5 Rab7-GFP positive vesicles motility in cortical neurons at DIV 10
The graphs show the distance (µm) covered by the vesicles in the inward (A) and
outward (B) bound directions. The bottom graphs show the velocity (µm/sec) of the
vesicles in the inward (C) and outward (D) bound directions. Wildtype (black bars),
heterozygous H304R/+ mice (gray bars), and homozygous H304R/R mice (blue bars).
Note: * shows statistical significance (1-way ANOVA, p<0.05).

The outward bound Rab7-GFP positive vesicles in heterozygous H304R/+
showed a significant increase in the distance (µm) covered as compared to the
wildtype and homozygous H304R/R mice (One-way ANOVA, p<0.05) (Figure 55). The velocities of both inward and outward bound Rab7-GFP vesicles were
comparable between all three genotypes (Figure 5-5).
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5.3

Conclusions

The preliminary motility studies with synaptophysin-RFP and Rab7-GFP positive
vesicles in the hippocampal and cortical primary neurons from the H304R mice
presented highly variable and sometimes contradictory results. There could be
multiple reasons behind these variable results, such as:


Pooling of the primary neurons from the male and female embryos
together for each genotype might have masked any motility differences,
especially in the heterozygous H304R/+ mice neuronal cultures. We
previously showed that the male heterozygous H304R/+ mice are affected
more than the female heterozygous H304R/+ mice in their motor skills
phenotype. A better approach would be to perform the motility studies on
primary neuron cultures that are grown separately based on the genotype
and gender of the embryos.



The primary neurons were collected from the E16.5 developing embryos
that are hard to isolate and grow consistently in vitro.



The motility videos were collected from the longest visible axonal
projection in culture for the data analysis. The classification of “inward”
and “outward” direction bound moving vesicles may not be accurate if the
longest visible axonal projection was not an axon. Only the axons are
known to have an established microtubule polarity and the dendrites have
microtubules arranged in a random fashion with mixed polarities. Hence,
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this could have introduced another source of variability in the direction
based motility data comparison.


The motility analysis was done on the primary neurons that were grown in
vitro for 10 (DIV 10) or 14 (DIV 14) days. Performing motility analysis at a
range of early and late time points might reveal some alterations in the
motility phenotype.

In conclusion, performing future motility experiments with the abovementioned
considerations might help resolve the variability issue observed in the preliminary
study results. Additionally, at the time of this preliminary study we chose neurons
from the central nervous system (CNS) due to the established experimental
protocols in CNS neurons. Future motility studies should also be performed on
the motor and sensory neurons from the peripheral nervous system in the H304R
mouse model.
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CHAPTER 6: DISCUSSION
6.1

All dynein mutations don’t act the same

The motor protein dynein is responsible for retrograde transport of crucial
cargoes from the axonal tip to the soma in neurons. Various studies show the
specific role of dynein in neuronal functions such axonal transport (He et al.,
2005), retrograde signaling (Perlson et al., 2009), protein degradation and
recycling (Ligon et al., 2005), and neuronal migration (Ori-McKenney and Vallee,
2011). It is evident that neurons need a robust retrograde mediated transport for
its growth, maintenance, and survival. Hence, it is not surprising to see that
several mutations in cytoplasmic dynein have been reported in human
neurodegenerative diseases. These dynein mutations (Table 1-2) are associated
with motor and sensory neuropathies such as Charcot-Marie-Tooth type 2O
(CMT2O) (Weedon et al., 2011), Spinal Muscular Atrophy with Lower Extremity
Dominant (SMA-LED) (Harms et al., 2012) (Tsurusaki et al., 2012), in
malformations of cortical development (MCD) (Poirier et al., 2013), in intellectual
disability (Willemsen et al., 2012), and congenital cataract and gut dysmotility
(Gelineau-Morel et al., 2016).
The spectrum of neurodegenerative diseases in humans point out the
susceptibility of neurons to the dynein mutations in the peripheral and central
nervous systems. Perhaps, it is the distinct structure and function of neurons that
make them very sensitive to the altered functions of mutant dynein. For example,
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the motor neurons have very long axons that can grow up to a meter in humans
and require robust axonal transport for its maintenance (Levy and Holzbaur,
2006). Not surprisingly, about 18 distinct mutations in dynein heavy chain are
reported thus far in SMA-LED patients with peripheral motor neuron loss (Scoto
et al., 2015). The same study also reported about 16 mutations in dynein heavy
chain associated with malformations of cortical development (MCD), signifying
the vulnerability of neurons in the central nervous system to the mutant dynein
functions.
The dynein heavy chain (DHC) mutations in motor domain and tail domain alter
the dynein function differentially, thus giving rise to a spectrum of human
neuropathies spanning both the peripheral and central nervous systems in
humans (Scoto et al., 2015). Interestingly, the same DHC mutation can cause
two different diseases as well. For examples, the H306R mutation in DHC is
associated with both CMT2O (Weedon et al., 2011) and SMA-LED (Tsurusaki et
al., 2012). In fact, both CMT2O and SMA-LED patients exhibit similar clinical
symptoms such as muscle weakness and wasting in legs, developmental
milestone delays, skeletal deformities, joint contractures, and gait problems. The
only difference is that the CMT2O patients also exhibit sensory loss symptoms, in
addition to the motor deficits.
Various mutations exist in the DHC peptide with overlapping phenotypes, but
they all do not cause just one exact same neuropathy in humans. Rather these
DHC mutations cause different type of neuropathies, thus signaling that the
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mutations alter proteins in different ways. Our previous studies with filamentous
fungi N.crassa also recapitulated similar observations where various dynein
mutations resulted in distinct fungal morphology and vesicular motility
(Sivagurunathan et al., 2012). Because different dynein mutations do not behave
the same and cause the same phenotype in humans, there is a possibility that
there might be a distinct molecular mechanism of disease behind each dynein
mutation.

6.2

Relevance of H304R Mouse Model

Relevance of heterozygous H304R/+ mice
One key feature of Charcot-Marie-Tooth type 2O (CMT2O) disease is the
heterogeneity of its onset and the severity of the clinical symptoms in patients.
Family members with the same CMT2O dynein mutation reported variable ages
of onset and the severity of the clinical symptoms expressed. Similar trends were
observed in our study with the heterozygous H304R/+ mice behavioral and
phenotypic characteristics. The heterozygous H304R/+ mice showed variable
onset of phenotype, i.e. early onset of reduced all limbs grip strength and rotorod
test defects, while late onset of reduced front grip strength and tail suspension
reflex. Some heterozygous H304R/+ mice expressed a mild phenotype, whereas
some expressed a more severe phenotype just like as seen in the human
patients with the corresponding autosomal dominant CMT2O mutation.
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A possible explanation to this heterogeneity might lie in the fact that dynein
heavy chains (DHC) dimerize with each other and interact with other subunits
(like intermediate chains, light intermediate chain, & light chains) to form a
functional dynein motor complex. In the heterozygous H304R/+ mice, there
would be a mix of DHC monomers that have been translated from the
heterozygous DHC alleles (H304R/+). From the mix of wildtype and H304R
mutant DHC monomers, three possible combinations of dynein population may
arise –


A quarter population of dynein containing wildtype DHC dimers only



A quarter population of dynein containing mutant DHC dimers only



And half of the population of dynein containing DHC dimers of 1 wildtype
monomer dimerized with 1 mutant DHC monomer

Thus, at any given time, a heterozygous H304R/+ mouse cells will have all three
types of DHC dimers combination – wildtype, homozygous, and heterozygous
DHC dimers. There could be a “dose-dependent” modulation of dynein motor
function depending on what percentage of wildtype, homozygous, and
heterozygous DHC dimers are present and interacting functionally with other
dynein subunits at a given time. The variable level of DHC dimers may also affect
the interaction of the dynein motor complex with its other binding partners and/or
cargoes. Future biochemical tests with purified dynein from H304R mouse model
can reveal key insights on the cellular dynamics that happen when different
“doses” of wildtype, homozygous, heterozygous DHC dimers are around in a cell.
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One key experiment will be to test the binding efficiency of wildtype,
homozygous, and heterozygous DHC dimers with other dynein subunits and key
binding partners of dynein such as dynactin, BicD, Lis1, Nudel etc..
Another key observation in the heterozygous H304R/+ mice was the genderbased differences in the exhibition of the motor skills phenotypic defects. Overall,
the male heterozygous H304R/+ mice appeared to be more affected by the
dynein mutation as evident in the various motor-skills assays. In contrast, the
female heterozygous H304R/+ mice showed mild to no defects in the exhibition
of the motor skills phenotypic defects. A potential reason behind this genderbased observation could be the presence of the neuroprotective effects of
estrogen in the female mice (Green and Simpkins 2000). Thus, the female
heterozygous H304R/+ mice appear to be less sensitive to the effects of the
dynein mutation on their motor skills phenotype. Similar observations were made
in a small study with CMT1A patients where the male patients were shown to
have significantly reduced muscle strength in their lower limbs as compared to
the female patients (Wozniak and Gess, 2015).
Relevance of homozygous H304R/R mice
The homozygous H304R/R mice exhibited severe symptoms of atypical tail
suspension, reduced grip strength and rotorod deficits right from an early age.
The onset and the severity of homozygous H304R/R phenotype recapitulated the
severity of SMA-LED symptoms as seen in another and the only reported
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homozygous DHC mutation (R399G) (Scoto et al., 2015). Offspring with this
DHC homozygous R399G mutation showed an early onset and severe motor
symptoms as compared to the parents that were heterozygous for the same DHC
mutation.
Furthermore, both male and female homozygous H304R/R mice showed similar
trends of deficiencies in their behavioral phenotype, unlike the heterozygous
H304R/+ mice that showed gender-based deficiencies in their phenotype
(Sabblah et al., 2018). As in the previous publication, only the male heterozygous
H304R/+ mice primarily exhibited an altered motor skills phenotype in most
behavioral tests. The female heterozygous H304R/+ mice exhibited little to no
difference in its behavioral phenotype as compared to the wildtype mice. This key
difference between the heterozygous H304R/+ and homozygous H304R/R mice
indicates that the homozygous H304R/R mutation has a distinct and more severe
effect on the dynein function that may not altered by the gender differences of the
mice.
Overall relevance of H304R mice in understanding the dynein function
In conclusion, both heterozygous H304R/+ and homozygous H304R/R mice with
DHC mutations recapitulate the onset and the phenotypes as seen with the
reported heterozygous (H306R) and homozygous (R399G) dynein mutations in
humans. Hence, our H304R mouse model would serve as a relevant and useful
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mouse model to understand the molecular mechanism of mutant dynein in
human neuropathies.

6.3

Comparison of H304R Mouse Model with Other Dynein Mouse Models

Previously reported mutant DHC mice were generated using ENU or radiation
based mutagenesis method that exhibited dominant neurological phenotypes
(Hrabe de Angelis et al., 2000) (Duchen, 1974). The mutant DHC mice were
Legs at odd angle (Loa) mice with F580Y mutation, Cramping (Cra) mice with
Y1055C mutation, and Sprawling (Swl) mice with a nine base-pair deletion
[GIVT]1040[A] mutation in the cytoplasmic dynein heavy chain gene. Even
though all three mutations were located in the tail domain of the dynein heavy
chain, the Loa, Cra and Swl did not display the same exact phenotype.
A key difference is that the H304R mouse model has the corresponding dynein
mutation (H306R) that is reported to cause neuropathies in humans (CMT2O and
SMA-LED) (Tsurusaki et al., 2012; Weedon et al., 2011). In contrast, the
mutagenesis generated Loa, Cra, and Swl mice models do not have a
corresponding mutation that is associated with any human neuropathies. Hence,
it is hard to correlate their findings as a basis for human neuropathy. Another key
difference between H304R mice and other DHC mice is that homozygous
Loa/Loa, Cra/Cra, and Swl/Swl were embryonically lethal or did not survive 24
hours post birth due to inability to move and feed (Hafezparast et al., 2003)
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(Zhao et al., 2016). In contrast, the homozygous H304R/R mice survived post
birth and had a normal lifespan.
The H304R mouse model shares many commonalities with other published
models of dynein heavy chain mutation Loa, Cra, and Swl. The first commonality
is that all the mutations are located in the tail domain of the dynein heavy chain.
Shared phenotypes between H304R model and Loa/+, Cra/+ and Swl/+ mice are
– atypical reflex of clenching hind limbs closer to the body upon tail suspension,
normal life span, gait abnormalities, reduced grip strength in hind limbs, and
thinner sciatic nerves. Additionally, H304R/+ and H304R/R mice showed deficits
in rotarod performance similar to Loa/+ mice.
In conclusion, the H304R model and previously published DHC mice model
display a varying range of phenotypes. The severity of the mouse DHC mutations
on the dynein function varies in the following order – the homozygous Loa/Loa,
Cra/Cra and Swl/Swl are the most severe mutations, followed by the
homozygous H304R/R and heterozygous Loa/+, Cra/+ and Swl/+ moderate
mutations, and finally the heterozygous H304R/+ mild mutation (Figure 6-1).

134

MOUSE
MUTATIONS

No
Mutation

Loa/+
Cra/+
Swl/+

H304R/+

H304R/R

LETHAL

NO SYMPTOM
HUMAN
MUTATIONS

No
Mutation

Loa/Loa
Cra/Cra
Swl/Swl

H306R/+
(CMT2O)

R399G/G

Figure 6-1 Severity of phenotypes associated with DHC mutations
Comparison of the severity of mouse DHC mutations with the human DHC mutations. The severity of the
phenotype associated with the DHC mutation increases from left to the right.
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6.4

Future Sensory Characterization Work of H304R Mouse Model

Collectively behavioral assessments like tail suspension, grip strength, and
rotarod performance tests have given us some robust insights into the motor
phenotype of H304R mouse model. Neuromuscular junction (NMJ) analysis gave
additional evidence supporting the defective motor phenotype of H304R mouse
model (Sabblah et al., 2018). NMJ analysis revealed the deficiencies in the
morphology and complexity in heterozygous H304R/+ and homozygous
H304R/R male mice. The synaptophysin occupancy in NMJs were also found to
be faulty, indicating a loss of motor neuron functionality in heterozygous H304R/+
and homozygous H304R/R male mice. The reason why the motor neurons are
not functional in mutant H304R mice is yet to be explored.
However, investigating the motor characterization is only one part of the equation
in understanding a motor-sensory neuropathy like CMT2O. Multiple studies have
indicated dynein’s role in sensory neuron maintenance and survival (Deinhardt et
al. (2006); (Saxena et al., 2005; Yano et al., 2001). In parallel, the previously
published dynein heavy chain mutant Loa/+, Cra/+ and Swl/+ mice have also
reported sensory deficits. Heterozygote Loa/+ and Swl/+ mice reportedly had
reduced size of dorsal root and fewer neurons in their lumbar dorsal root ganglia
(Chen et al., 2007). Furthermore, Loa/+ and Swl/+ also showed abnormal
proprioceptive phenotype as indicated by the absence of H-reflex and specific
loss of proprioceptive sensory neurons as compared to the wildtype mice.
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Interestingly, Loa/+ and Swl/+ mice also had thinner sciatic nerves as compared
to the wildtype control mice. The Swl/+ mice showed no difference in the latency
to tail withdrawal as compared to the wildtype control mice. The Cra/+ mice
displayed subtler sensory phenotype than the Loa/+ and Swl/+ mice and had
reduced size of its dorsal root due to the loss of large caliber axon (potentially
proprioceptive) neurons (Dupuis et al. (2009). In conclusion, CMT2O patients
and all the other dynein mutant mice (Loa/+, Cra/+, and Swl/+) showed mild to
severe sensory phenotype and subsequently raised a question on the sensory
phenotype of the H304R mouse model. Hence, I started investigating the
sensory phenotype of H304R mice with tail flick test, sciatic nerve thickness
measurements, and optimizing the protocol to identify the dorsal root ganglia
neuronal subpopulation.
Preliminary results from the tail flick tests showed a quicker latency to tail
withdrawal from the pain stimulus in the homozygous H304R/R mice. One
possible explanation is that the homozygous H304R/R mice have hypersensitivity
to thermal pain stimulus due to reduced pain threshold as commonly seen in
mice models with sciatic nerve injury and persistent sensory neuropathic pain
(Wang et al., 2009; Yajima et al., 2002). Incidentally, severely affected CMT2O
patients also reported having neuropathic pain (Weedon et al., 2011).
Next, a closer examination of peripheral nervous system revealed thinner sciatic
nerves and reduced axonal counts in both the heterozygous H304R/+ and
homozygous H304R/R mice. It would be interesting to learn if the sciatic nerve
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thinning in homozygous H304R/R is caused by the loss of motor and/or sensory
neurons. One way to test this would be to stain the sciatic nerve cross sections
with unique markers for both motor and sensory neurons. Then the number of
motor and sensory axons passing through the sciatic nerve can be counted and
normalized against the total number of neurons (labeled with a pan-neuronal
marker). This would help in identifying if any alteration in the number of motor
and/or sensory neurons led to thinner sciatic nerve in homozygous H304R/R
mutant mice.
To advance the sensory characterization, it would be of critical importance to
identify the neuronal subpopulation inside the dorsal root ganglia (DRG) as well
of the H304R mouse model. Previous work on Swl/+ mice revealed a significant
loss of proprioceptive neurons in the lumbar DRG (Chen et al., 2007). My
optimization work established the working protocol of how to stain and identify
nociceptive and proprioceptive subpopulations in the same section of the DRG of
H304R mice. The next step would be to stain DRG sections from the wildtype,
heterozygous H304R/+, and homozygous H304R/R mice with the unique
markers for each neuronal subpopulation. Then the number of neuronal cells
positive for nociceptive marker or proprioceptive marker can be counted and
normalized over the total count of neurons in the DRG. The results would yield if
there are any differences in the neuronal subpopulations count in the H304R
mouse model, and potentially reveal the neuropathology of mutant dynein in
sensory dysfunction.
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6.5

Potential Dynein Disruptions in the H304R Mice and Future Studies

Our preliminary studies revealed both motor and sensory defects in our H304R
mouse model. Because large sized motor and sensory neurons have high
demands for energy and require robust axonal transport, it is not surprising that
motor and sensory neurons are vulnerable to the mutations that may alter the
dynein functions in retrograde axonal transports (LaMonte et al., 2002; OriMcKenney et al., 2010). Dynein has an established role in transporting nerve
growth factors via activated trk signaling from the neuronal tip to the soma for
neuronal survival (Heerssen et al., 2004; Mitchell et al., 2012; Yano et al., 2001).
Impaired retrograde signaling of growth factors or neurotropic factors in sensory
neurons has been shown to develop peripheral neuropathy phenotypes in mice
(Rishal et al., 2012). Based on this literature evidence, I speculate three different
potential mechanism of the H304R mutation in the disease progression.
The first disease mechanism is that the dynein mutation affects the retrograde
signaling of endosomes with the neurotrophic factors. This would lead to a loss of
sensory neurons in the H304R mice. As evident from my preliminary work with
the sensory phenotype characterization, I think the nociceptive (pain sensing)
subpopulation of the sensory neurons might be affected more as seen in the
quick tail withdrawal latency in the mutant H304R mice. Hence, impaired
retrograde signaling leading to the loss of nociceptive sensory neurons ultimately
causes the altered sensory phenotypes such as altered tail withdrawal, thinner
sciatic nerves, and a loss of axonal counts in the heterozygous H304R/+ and
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homozygous H304R/R mice. Investigating the robustness of retrograde signaling
of trk receptors upon activation of growth factors such as brain derived
neurotrophic factors (BDNF), nerve growth factor (NGF), or neurotrophins (NTs)
would be of critical importance in understanding the role of mutant dynein in the
H304R mice.
The second disease mechanism is the impaired retrograde transport of length
sensing cellular factors leading to an altered growth of sensory neurons. This is
based on an interesting study that revealed a role of dynein in maintaining the
sensory neurons length (Ori-McKenney et al., 2010). In this study, adult sensory
neurons in the heterozygote Loa/+ mice had longer neurites than the wildtype
controls when grown in vitro. Additionally, heterozygote Loa/+ mice showed a
similar trend of significantly longer axis from cell periphery to the nucleus in
embryonic fibroblasts as compared to wildtype controls. These results indicated
that dynein might have a role in transporting the length sensing cellular factors
needed for sensory neuron axonal length maintenance. Based on the evidence
presented above I speculate that the H304R mice may have an impaired
retrograde transport of length sensing cellular factors. And that this may lead to
an alteration in the sensory neuron lengths. Hence, it would be an exciting idea
to measure and compare the lengths of the sensory neurons in vitro from the
H304R mice to reveal any alterations in the sensory neuron lengths.
Lastly, the third possible mechanism for the dynein dysfunction in the H304R
mice could be a biochemical interaction defect based on the location of the
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H304R mutation on the dynein heavy chain (DHC) peptide. The H304R mutation
is located in the tail domain of the DHC peptide. The H304R mutation lies within
the homodimerization region of the tail domain in the DHC. The presence of the
H304R mutation in the homodimerization region may cause a hindrance to the
binding of two DHC monomers to form a functional DHC dimer. The H304R
mutation could also contribute to interference in the interactions of the DHC to
other dynein subunits like dynein intermediate chains (DICs) and dynein light
chains (DLCs). The interactions with DICs and DLCs allow for the indirect
interaction of the DHCs to its binding factors such as dynactin, Lis1, BicD and
these binding factors have been implicated in the proper functioning of the
neurons such as neurofilament transport, clearance of misfolded proteins, and
neuronal migration. Thus, it would be insightful to perform future studies to
investigate the functional binding of the mutant DHC with other dynein subunits
and binding factors using biochemical assays. These biochemical assays may
potentially uncover any altered dynein interaction that may contribute to the
pathogenesis of the disease as discussed above.
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ABSTRACT
Dynein is an essential motor protein required for the maintenance and survival of the
cells. Dynein forms a motor complex to carry intracellular cargoes like organelles,
growth factors, peptides, hormones etc. along the microtubules inside the cells. In
neurons, the dynein is the retrograde motor protein that moves cargoes from the neuronal
tip to the neuronal soma along the length of an axon. Dynein has an established role in
the neuronal nuclei migration, transport of neuronal survival signals and growth factors,
organelle positioning inside neurons etc. Hence, it is not very surprising that numerous
mutations in dynein have been reported in association with neurodegenerative diseases in
humans. The first mutation (H306R) in dynein heavy chain was reported to cause
Charcot-Marie-Tooth Type 2O disease (CMT2O) in humans. CMT2O patients display
motor-sensory neuropathy symptoms such as muscle weaknesses and wasting in legs,
skeletal deformities like pes cavus (high foot arching), difficulty in walking, and a loss of
sensation.
We developed a novel knock-in H304R mouse model with the corresponding CMT2O
linked dynein mutation to understand the disease’s molecular mechanism. We
investigated and characterized the motor-sensory phenotype of the H304R mouse model
(wildtype, heterozygous (H304R/+) and homozygous (H304R/R) mice). First, we started
with testing mice on motor skills behavior tests such as tail suspension reflex, grip
strength test, and rotarod test at 3, 6, 9 and 12 months of age. Both male and female
groups of heterozygous (H304R/+) mice displayed mild defects in tail suspension reflex,
grip strength, and rotarod performance at a later age time point. In contrast, homozygous
(H304R/R) mice exhibited severe defects in the tail suspension reflex, grip strength, and
rotarod performance right from an early age. Next, I analyzed the sensory phenotype of
the H304R mouse model. Homozygous H304R/R mice appeared to have thinner sciatic
nerve, reduced total fascicular area of the sciatic nerve, and significantly quicker latency
to tail withdrawal from a pain stimulus.
Collectively, our motor and sensory characterization studies reveal that H304R dynein
mouse model recapitulates the phenotype associated with CMT symptoms. Hence, the
H304R model is a useful tool in understanding the dynein function in the onset and
progression of CMT2O in humans.
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